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ABSTRACT 
Acetyl-CoA carboxylase is a biotin-dependent, multifunctional enzyme that catalyzes the 
first committed step in fatty acid synthesis. The Escherichia coli enzyme is composed of a 
homodimeric biotin carboxylase, biotinylated biotin carboxyl carrier protein (BCCP), and an 
α2β2 heterotetrameric carboxyltransferase. Catalysis by acetyl-CoA carboxylase proceeds via two 
half-reactions. In the first half-reaction, biotin carboxylase catalyzes the ATP-dependent 
carboxylation of biotin, which is covalently attached to BCCP, to form carboxybiotin. In the 
second half-reaction, carboxyltransferase transfers the carboxyl group from carboxybiotin to 
acetyl-CoA to form malonyl-CoA. All biotin-dependent carboxylases are proposed to have a 
two-site ping-pong mechanism where the carboxylase and transferase activities are separate and 
do not interact. This posits two hypotheses: either biotin carboxylase and BCCP undergo the first 
half-reaction, BCCP dissociates, and then BCCP interacts with carboxyltransferase to complete 
the second-half reaction, or all three components form a macromolecular enzyme complex. To 
determine which hypothesis is correct, a steady-state enzyme kinetic analysis of E. coli acetyl-
CoA carboxylase was carried out. The results indicated the two active sites of acetyl-CoA 
carboxylase interact. Both in vitro and in vivo pull-down assays demonstrated that the three 
components of E. coli acetyl-CoA carboxylase form a multimeric complex and that complex 
formation is unaffected by acetyl-CoA, AMPPNP, and mRNA coding for carboxyltransferase.  
 The second study focuses on the crystallization of part of the acetyl-CoA carboxylase 
complex. To date, the three-dimensional structures of the individual subunits, except the N-
terminal domain of BCCP, have been solved; however, the structural basis for how BCCP reacts 
with biotin carboxylase or carboxyltransferase is unknown. Therefore, we report here the first 
crystal structure of E. coli BCCP complexed with biotin carboxylase to a resolution of 2.49 Å. 
viii 
 
The protein-protein complex shows unique quaternary structure and two distinct interfaces for 
each BCCP monomer. The structure supports a model by which biotin protein ligase can 
biotinylate the complex. The BCCP binding sites are unique compared to phylogenetically 
related biotin-dependent carboxylases and therefore, provide novel targets for developing 
antibiotics against bacterial acetyl-CoA carboxylase. Taken together, these findings provide 
structural and functional insight into the regulation and complex formation of E. coli acetyl-CoA 
carboxylase.  
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CHAPTER 1 
INTRODUCTION 
 
Biotin 
Background 
Vitamin H or B7, commonly known as biotin, is required for life by animals, plants and 
bacteria. Many prokaryotes and plants synthesize their own biotin while mammals obtain this 
nutrient through intestinal uptake after synthesis by normal flora of the gut or consumption of 
foods such as egg yolk, organ meats, nuts and some vegetables. The first reference to biotin in 
the literature is from Wildiers (1901), who found that a substance he termed “bios”, later 
determined to be biotin and other nutrients, was necessary for yeast growth. Biotin was isolated 
from egg yolk (Kogl and Tonnis, 1936) and subsequently from beef liver (Vitamin H) and 
Rhizobium sp. (cofactor-R), which were all found to be the same compound (Du Vigneaud et al., 
1941; Gyorgy et al., 1940; Melville et al., 1940). Additionally, Bateman (1916) found that egg 
whites caused gastrointestinal problems and malabsorption of protein in dogs, rats, rabbits and 
humans. Shortly after, Eakin et al. (1941) identified avidin as the protein in egg whites that 
causes a dietary deficiency of biotin, due to binding biotin with a Kd = 10
-15
 M (Green, 1990). 
The next step was determination of the structure of biotin. 
Structure 
Biotin is a bicyclic compound containing a ureido ring fused cis to a tetrahydrothiophene 
ring (Figure 1.1). The structure of biotin was elucidated by Du Vigneaud and Melville (1942) 
and the first de novo synthesis was described by Harris et al. (1944). The molecule has a 
molecular weight of 244.31 and of the eight stereoisomers that exist, only D-(+)-biotin is found 
and active in nature (Streit and Entcheva, 2003). A valeric acid side chain is attached to one of 
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the three contiguous chiral carbons in the thiophane ring. Covalent attachment to biological 
molecules, such as proteins and nucleic acids, occurs via the valeric acid side chain (Hermanson, 
2008) and allows for convenient detection of these biotinylated compounds using avidin (Green, 
1990). The discovery of the unique interaction between avidin and biotin has led to the 
development of several techniques in biotechnology for the detection of biotinylated proteins and 
nucleic acids (Diamandis and Christopoulos, 1991). In contrast to the beneficial biotechnical 
uses of biotin, nature synthesizes biotin for a different reason. 
 
Figure 1.1 Structure of biotin. A) D-(+)-biotin. B) The imidate form of A. 
 
Biosynthesis 
The expression of several genes is required for biotin biosynthesis. Escherichia coli 
expresses the biotin biosynthetic genes in the bioABFCD
1
 operon as well as the bioH gene 
located outside of this operon (Marquet et al., 2001; Otsuka and Abelson, 1978). This is a bi-
directional operon in that the bioB, bioF, bioC, and bioD genes are rightward transcribed and the 
bioA gene is leftward transcribed (Streit and Entcheva, 2003). Biotin biosynthesis begins with 
                                                 
1
Throughout the text, genes will be represented in italics and proteins will be represented as a plain text version of 
the gene or by their common name. For example, bioB is the gene encoding the protein BioB or biotin synthase. 
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the conversion of either malonyl-CoA or malonyl-ACP into malonyl-CoA (or ACP) methyl ester 
via the S-adenosyl-L-methionine (SAM)-dependent methylation carried out by BioC (Lin et al., 
2010) (Figure 1.2). This molecule then replaces acetyl-CoA in fatty acid synthase and undergoes 
two cycles of condensation, reduction, dehydration and reduction to produce a C7, pimeloyl-
ACP methyl ester, which is then hydrolyzed by BioH to yield pimeloyl-ACP and methanol (Lin 
et al., 2010). Next, the condensation of pimeloyl-ACP and L-ala produces 7-keto-8-
aminopelargonic acid (KAPA) and the reaction is catalyzed by KAPA synthase (BioF) (Streit 
and Entcheva, 2003). SAM then acts as an amino donor to KAPA to produce 7,8-
diaminopelargonic acid (DAPA) in a reaction catalyzed by DAPA synthase (BioA) (Breen et al., 
2003). Dethiobiotin synthetase (BioD) is responsible for the ATP-dependent closure of the 
ureido ring, which creates dethiobiotin from DAPA (Marquet et al., 2001). Finally, biotin 
synthase (BioB) uses two equivalents of SAM to close the tetrahydrothiophene ring creating 
biotin (Figure 1.2) (Fugate and Jarrett, 2012). Currently, the mechanism of biotin synthase is 
uncertain, but the sulfur atom is thought to be donated from an [2Fe-2S]
2+
 cluster (Fugate and 
Jarrett, 2012). Biotin can now be attached to the biotin carboxyl carrier protein (BCCP) of biotin-
dependent enzymes to act as a carboxyl carrier for carboxylation, decarboxylation, and 
transcarboxylation reactions in various organisms. 
Biotin-dependent Enzymes 
Background 
Biotin-dependent enzymes use the biotin prosthetic group to transfer or remove carboxyl 
groups. They all proceed by two half-reactions that involve the carboxylation and then  
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Figure 1.2 Biosynthesis of biotin in E. coli. Abbreviations: SAH, S-adenosylhomocysteine; 
AMTOB, S-adenosyl-2-oxo-4-methylthiobutyric acid; 5′-DOA, 5′-deoxyadenosine. 
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decarboxylation of biotin at its 1′N and have been designated as having non-classical or two-site 
ping-pong mechanisms (Wood and Barden, 1977). These multifunctional enzymes are involved 
in a range of metabolic processes and are divided into three classes based on their use of the 
carboxyl group in carboxylation (Class I), decarboxylation (Class II), or transcarboxylation 
(Class III) (Figure 1.3). 
Class I: The Carboxylases 
The carboxylases represent the largest class of biotin-dependent enzymes and the only 
one of the three found in mammals. These enzymes are named after the acceptor molecule they 
carboxylate and include pyruvate carboxylase, propionyl-CoA carboxylase, 3-methylcrotonyl-
CoA carboxylase, acetyl-CoA carboxylase, geranyl-CoA carboxylase and urea amidolyase, 
which produce oxaloacetate, methylmalonyl-CoA, 3-methylglutaconyl-CoA, malonyl-CoA, γ-
carboxygeranyl-CoA and ammonia, respectively (Lombard and Moreira, 2011). They contain 
three subunits or domains depending on whether they are synthesized separately or on the same 
polypeptide chain: biotin carboxylase (BC), biotin carboxyl carrier protein and 
carboxyltransferase (CT). In the first half-reaction, BC catalyzes the ATP-dependent 
carboxylation of biotin that is covalently attached to the BCCP (Figure 1.3 A). The carboxyl 
group is derived from bicarbonate in all of the carboxylases (Rubio, 1986). The second half-
reaction, catalyzed by carboxyltransferase (CT), involves the transfer of the carboxyl group from 
biotin to an acceptor molecule. The carboxylases are important for gluconeogenesis, the 
catabolism of odd-chain fatty acids and branched chain amino acids, fatty acid synthesis, 
isoprenoid catabolism, and the utilization of urea as a nitrogen source. 
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Figure 1.3 Cartoon depiction of the biotin-dependent enzyme reactions and major subunits. A) 
carboxylases. B) decarboxylases. C) transcarboxylase. 
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Class II: The Decarboxylases 
The three biotin-dependent decarboxylases are membrane bound and found in anaerobic 
bacteria and archaea. These enzymes are named for the substrate they decarboxylate and include 
oxaloacetate decarboxylase, methylmalonyl-CoA decarboxylase, and glutaconyl-CoA 
decarboxylase. They consist of three main subunits: an α-subunit that has the carboxyltransferase 
activity, a β-subunit that catalyzes the decarboxylation and sodium transport, and a γ-subunit, 
which is usually the biotin carrying protein, except in oxaloacetate decarboxylase where it is 
attached to the flexible C-terminus of the α-subunit (Buckel, 2001; Jitrapakdee and Wallace, 
2003). In the first half-reaction, the α-subunit catalyzes the transfer of a carboxyl group from the 
substrate to biotin to form carboxybiotin. In the second half-reaction, biotin is decarboxylated, 
the carbon dioxide is released to the cytosol, a proton is transported into the cell, and one to two 
sodium ions are transported across the cytoplasmic membrane by the β-subunit (Figure 1.3 B) 
(Balsera et al., 2011). The transport of sodium to the periplasm generates an electrochemical 
gradient that can then be used for ATP synthesis (Hase et al., 2001), solute uptake (Pos and 
Dimroth, 1996), and flagellar motion (Berg, 2003; Kojima et al., 1999). 
Class III: Transcarboxylase 
Currently, only one enzyme falls into class III, transcarboxylase from Propionibacterium 
shermanii. Like the other classes, transcarboxylase is made up of three main subunits: six 12S 
subunits form a hexameric core, twelve 1.3S subunits carry the biotin prosthetic group and are 
attached to opposite ends of the 12S subunits, and three homodimers of the 5S subunit cap each 
end of the complex (Carey et al., 2004). In the first half-reaction catalyzed by the 12S subunit, 
carboxybiotin is generated by decarboxylation of methylmalonyl-CoA and subsequent formation 
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of propionyl-CoA (Figure 1.3 C). In the second half-reaction, the 5S subunit transfers the 
carboxyl group from carboxybiotin to pyruvate to produce oxaloacetate (Jitrapakdee and 
Wallace, 2003). This transcarboxylase reaction is important for propionate metabolism.  
Biotin Protein Ligase 
Background 
Biotin protein ligase (BPL), also known as BirA as well as holocarboxylase synthetase, is 
the enzyme responsible for post-translational attachment of biotin to the various biotin-
dependent enzymes. It was originally thought that each biotin-dependent enzyme had its own 
ligase. However, gene sequence analysis and studies of biotinylation of apocarboxylases by 
bacterial and eukaryotic BPLs have shown that each organism contains one BPL that can 
biotinylate multiple biotin-dependent enzymes (Chapman-Smith and Cronan, 1999b; Leondelrio 
et al., 1995; McAllister and Coon, 1966). The enzyme undergoes two half-reactions that 
covalently link biotin to a specific lysine residue on the carrier protein of each biotin-dependent 
enzyme. First, BPL catalyzes the formation of biotinoyl-5′-AMP from biotin and ATP. Second, 
biotin is transferred from the biotinoyl-5′-AMP adduct to form an amide bond between the ε-
amino group of lysine and the carboxylic acid on the valeric acid side chain of biotin (Figure 1.4) 
(McAllister and Coon, 1966). The structure of these enzymes have been shown to be similar to 
tRNA synthetases, which catalyze a very similar type of reaction (Leatherbarrow et al., 1985; 
Safro and Mosyak, 1995).  
Regulation of Biotin Protein Ligase 
BPL was found to be a bi-functional enzyme when it copurified with the DNA of the bio 
operon (Barker and Campbell, 1981). In E. coli, BPL is a 35.5 kDa protein that has an N-
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terminal domain with a DNA binding helix-turn-helix motif (Wilson et al., 1992). In the absence 
of BCCP, the sole biotinylated protein in E. coli, the co-repressor biotinoyl-5′-AMP, remains 
tightly bound to BPL (Prakash and Eisenberg, 1979). The buildup of BPL-biotinoyl-5′- 
  
Figure 1.4 Biotin attachment to biotin-dependent carrier proteins. 
 
AMP complex causes dimerization, which allows binding to the 40 bp biotin operator, bioO 
(Streaker and Beckett, 1998) . This down-regulates transcription of the biotin biosynthetic genes 
(Prakash and Eisenberg, 1978). Sequence analysis of other microorganisms show that the N-
terminal BPL domain and the operon sequence is highly conserved, suggesting biotin synthesis is 
regulated in a similar manner in other organisms that synthesize biotin (Rodionov et al., 2002). 
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In contrast, gene sequence analysis suggests there are no sequences indicative of DNA binding in 
the BPL of organisms that do not synthesize their own biotin (Chapman-Smith and Cronan, 
1999b). Finally, synthesis of apoBCCP causes derepression of the biotin operon because 
conversion of biotinoyl-5′-AMP to biotinylated BCCP and AMP causes BPL to lose its DNA 
binding function (Cronan, 1988). Ultimately, this system works to sense the biotin requirements 
of the cell and express biotin as needed to biotinylate acetyl-CoA carboxylase. 
Acetyl-CoA Carboxylase 
Background 
 Acetyl-CoA carboxylase (ACC) from E. coli is the focus of the research in this 
dissertation and thus will be described in detail. Relevant aspects of its structure and function 
will be compared to other carboxylases and its significance as an antibacterial target will also be 
considered. 
Acetyl-CoA carboxylase was discovered when Wakil et al. (1958) showed that avidin 
inhibited the conversion of acetyl-CoA to palmitate in enzymatic fractions from avian livers. 
Acetyl-CoA carboxylase catalyzes the first committed step in the biosynthesis of long chain fatty 
acids in all plants, animals, and bacteria (Wakil et al., 1983). All acetyl-CoA carboxylases 
catalyze the conversion of acetyl-CoA to malonyl-CoA by two half-reactions. The first half-
reaction, catalyzed by biotin carboxylase, is the ATP-dependent carboxylation of the vitamin 
biotin, which is covalently attached to the carrier protein (Reaction 1 in Scheme 1.1) (Alberts et 
al., 1969). In the second half-reaction, carboxyltransferase transfers the carboxyl group from 
biotin to acetyl-CoA to form malonyl-CoA (Reaction 2 in Scheme 1.1) (Alberts et al., 1971; 
Guchhait et al., 1971).  
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Scheme 1.1 Acetyl-CoA carboxylase half-reactions and sum. 
 
Subunit Arrangement  
The subunit architecture of acetyl-CoA carboxylase from bacteria to humans has been 
divided into either type I fatty acid synthesis (FAS I) or type II fatty acid synthesis (FAS II) 
(Figure 1.5) (Rock and Cronan, 1996). In FAS I, proteins are expressed as multiple domains on a 
single polypeptide chain. In contrast, FAS II proteins are expressed as dissociated parts that 
interact to catalyze the reaction (Rock and Cronan, 1996).  
Acetyl-CoA carboxylase from E. coli is a model of a FAS II enzyme. It is made up of 
four separately expressed proteins that form its three subunits: a homodimeric biotin 
carboxylase, a biotinylated biotin carboxyl carrier protein, and an α2β2 heterotetrameric 
carboxyltransferase (Figure 1.5). The genes for BCCP (accB) and BC (accC) are cotranscribed 
from an accBC minioperon located at min 73.35 on the E. coli chromosome (James and Cronan, 
2004; Li and Cronan, 1992a). The genes encoding the α-subunit (accA) and β-subunit (accD) of 
CT are located on opposite sides of the chromosome at min 4.5 and 52.4, respectively (Li and 
Cronan, 1992b). Most bacteria and plant chloroplasts contain a multisubunit ACC similar to the 
one observed in E. coli (Cronan and Waldrop, 2002). 
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In contrast to the subunit arrangement in E. coli acetyl-CoA carboxylase, Mycobacterium 
sp., Streptomyces sp., and Myxococcus xanthus transcribe a gene that encodes an α-subunit di-
domain polypeptide containing the carboxylase and carrier protein and a gene that encodes a β-
subunit containing the carboxyltransferase as a di-domain polypeptide (Figure 1.5) (Kimura et 
al., 2000). These enzymes form α6β6 quaternary structures and have been termed acyl-CoA  
 
 
Figure 1.5 Domain architecture of acetyl-CoA carboxylase homologs. Domain architecture of 
various biotin-dependent enzymes are depicted as primary protein sequences indicated by 
colored boxes with residue numbers showing the length beneath. Domains and subunits that are 
similar are labeled and color coded to match. The organism the protein is expressed in proceeds 
the functional enzyme name: ACC (acetyl-CoA carboxylase), PCC (propionyl-CoA 
carboxylase), MCC (methylcrotonyl-CoA carboxylase), TC (transcarboxylase) or PC (pyruvate 
carboxylase). The PT (PC tetramerization) domain is shown in light orange and the BT domain is 
shown in teal and are involved in BC and CT domain or subunit interactions. 
 
carboxylases because they can catalyze the carboxylation of several acyl-CoAs, such as acetyl-
CoA, propionyl-CoA, and butyryl-CoA (Diacovich et al., 2002). For instance, the accA1 and 
accA2 genes from Streptomyces coelicolor encode nearly identical α-subunits that can interact 
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with either of the accB or pccB gene products (Rodriguez et al., 2001; Rodriguez and Gramajo, 
1999). Formation of an AccA and AccB complex yields an acyl-CoA carboxylase that was able 
to carboxylate acetyl-CoA, propionyl-CoA, and butyryl-CoA, whereas an AccA and PccB 
complex would not carboxylate acetyl-CoA (Diacovich et al., 2002). Furthermore, 
Mycobacterium tuberculosis expresses three α-subunits (accA1-3) and six β-subunits (accD1-6) 
(Gago et al., 2006). The β-subunits have differing affinities for acetyl-CoA, propionyl-CoA and 
butyryl-CoA. Additionally, an ε-subunit has been shown to be required for maximal catalytic 
activity of the α-β-subunit complex of M. tuberculosis (Gago et al., 2006) while in S. coelicolor, 
an ε-β subcomplex is formed first, which is then able to interact with the α-subunit and allow 
maximal activity (Diacovich et al., 2002). Human propionyl-CoA carboxylase and 3-
methylcrotonyl-CoA carboxylase are also expressed as an α-subunit containing the carboxylase 
and carrier protein and a β-subunit with the transferase function that forms an α6β6 dodecamer 
with a small domain incorporated into the α-subunit that mediates binding between subunits 
(Figure 1.5) (Huang et al., 2012; Huang et al., 2010). These observations provide a convincing 
argument that the carboxylases from M. tuberculosis, S. coelicolor and M. xanthus are 
evolutionary precursors to the eukaryotic form of ACC because fusion of the genes encoding the 
α- and β-subunits of these organisms ACCs could account for the arrangement observed in 
eukaryotes.  
In animals, the three components of ACC form different domains on one polypeptide 
chain (Figure 1.5) (Tanabe et al., 1975). Two isoforms of ACC expressed in humans. A 265 kDa 
isoform involved in fatty acid synthesis (ACC1) in the liver, adipose tissue and mammary glands 
and a 280 kDa isoform involved in the inhibition of fatty acid oxidation (ACC2) in the liver, 
heart, and skeletal muscle (Munday, 2002). These large multifunctional enzymes come together 
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to form dimeric quaternary structures in humans and tetramers in yeast (Brownsey et al., 2006; 
Tong, 2005; Vagelos et al., 1963).  
Individual Subunits of E. coli Acetyl-CoA Carboxylase 
Biotin Carboxylase 
The structure of biotin carboxylase from E. coli solved by Waldrop et al. (1994) was the 
first structure of a biotin-dependent carboxylase. Each monomer of BC contains 449 amino acid 
residues that are divided into three domains: an N-terminal domain, a B-domain or ATP-grasp 
domain, and a C-terminal domain (Figure 1.6) (Waldrop et al., 1994). The N-terminal domain, 
comprising residues Met1-Ile103, contains a β-pleated sheet with five parallel stands and a total 
of four α-helices (Waldrop et al., 1994). The ATP-grasp domain is made up of residues Val131-
Tyr203 and has three strands of β-pleated sheet and two α-helices (Thoden et al., 2000). The C-
terminal domain accounts for the largest part of BC spanning residues Arg208-Lys449. This 
domain contains an eight stranded antiparallel β-sheet, a smaller three stranded antiparallel β-
sheet and seven α-helices (Waldrop et al., 1994). Each monomer of the homodimeric BC 
contains a complete active site as opposed to residues being shared between monomers (Waldrop 
et al., 1994). The dimeric interface is formed between the C-terminal domains of the monomers, 
which each contribute about 1300 Å
2
 of buried surface area
2
 (Mochalkin et al., 2008). The biotin 
carboxylase from E. coli is similar in structure to the apoBC of Pseudomonas aeruginosa 
(Mochalkin et al., 2008) and the BC domains of P. aeruginosa 3-methylcrotonyl-CoA 
carboxylase (Huang et al., 2012), Rhizobium etli pyruvate carboxylase (St Maurice et al., 2007), 
Ruegeria pomeroyi propionyl-CoA carboxylase (Huang et al., 2010), Saccharomyces cerevisiae
                                                 
2
 Buried surface areas were calculated using the PISA program (Krissinel and Henrick, 2007) unless otherwise 
noted. 
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Figure 1.6 ATP-grasp domain conformations of E. coli biotin carboxylase. Biotin carboxylase homodimers with the left monomer 
color coded showing the N-terminal domain, B-domain, and C-terminal domain and the adjacent monomer in white. Atom colors are: 
carbon, white; nitrogen, blue; oxygen, pink; phosphate, orange and fluoride, cyan. A) open-open conformation with no bound ligands. 
B) closed-closed conformation with ATP bound in each active site and shown in sphere representation. C) open-closed conformation 
with ADPCF2P bound in the right active site and shown in sphere representation.
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ACC (Shen et al., 2004), and human ACC2 (Cho et al., 2010) because their alpha carbon atoms 
superimpose with an average RMSD
3
 of 1.35 Å and a range of 0.96-1.99 Å. 
The ATP-grasp domain has been observed in both open and closed conformations. 
Structures of biotin carboxylase without substrate bound display an ATP-grasp domain that is 
splayed open from the main body of the protein (Figure 1.6 A) (Waldrop et al., 2012). The BC 
domain from propionyl-CoA carboxylase (Huang et al., 2010), 3-methylcrotonyl-CoA 
carboxylase (Huang et al., 2012), and pyruvate carboxylase (St Maurice et al., 2007) are also 
observed in the open conformation in the absence of substrate. When ATP or an ATP analog 
binds to the monomer, the ATP-grasp domain rotates 45° to close down on top of the molecule 
and clasp it in the active site (Figure 1.6 B) (Waldrop et al., 2012). This is referred to as the 
closed conformation and several structures of the closed conformation have been solved with 
different ligands: ATP (Thoden et al., 2000), AMPPNP (Mochalkin et al., 2008), AMPCP 
(Mochalkin et al., 2008), as well as BC bound to all three substrates (Chou et al., 2009), and a 
pyruvate carboxylase structure of the BC domain bound to BCCP (Lietzan et al., 2011). 
The active sites of BC have been shown to display half-sites reactivity or an extreme 
form of negative cooperativity where the active sites must alternate turns catalyzing the reaction 
(Janiyani et al., 2001). This has been demonstrated by creating hybrid dimers where one 
monomer of BC is wild-type and the other monomer of BC was an inactive mutant. A total of 
four different heterodimers were made and would have been expected to show 50% of normal 
activity if the active sites acted independently. However, the inactive mutant monomers exerted a 
dominant negative effect on the wild-type monomer and the overall activity ranged from 0.4-
                                                 
3
 All root mean squared deviations (RMSD) were calculated using the program PDBefold (Krissinel and Henrick, 
2004) unless otherwise noted. 
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3.6% of wild-type (Janiyani et al., 2001). This is indicative that the two active sites undergo 
oscillating cycles of catalysis whereby when one monomer of BC is releasing product, the other 
monomer is binding substrates for catalysis. The structural evidence indicative of the oscillating 
catalytic mechanism was observed in a crystal structure where one BC monomer was bound to 
ADPCF2P in the closed conformation and the other monomer was in the open conformation with 
no molecule in the active site (Figure 1.6 C) (Mochalkin et al., 2008). 
Biotin carboxylase has also been shown to exhibit substrate-induced synergism 
(Blanchard et al., 1999b). BC catalyzes the slow hydrolysis of ATP in the absence of biotin, but 
in the presence of biotin, the activity of BC is increased 1100-fold. ATP is thought to have 
several non-productive binding modes and upon the binding of biotin, ATP assumes the most 
favorable conformation for formation of carboxyphosphate and subsequent carboxylation of 
biotin (Cronan and Waldrop, 2002). Structural evidence for a non-productive binding mode was 
observed in the crystal structure of E. coli biotin carboxylase bound to AMPPNP (Figure 1.7 A) 
(Mochalkin et al., 2008). In this structure, the γ-phosphate of ATP is curled back in a 
conformation that would not allow nucleophilic attack on the phosphate by the bicarbonate 
oxygen (Mochalkin et al., 2008). This is in contrast to the extended conformation of the γ-
phosphate that was observed in Staphylococcus aureus BC crystallized with AMPPNP and E. 
coli BC crystallized with ADPCF2P, which positions the γ-phosphate for the catalytic reaction 
(Figure 1.7 B and C) (Mochalkin et al., 2008). Additionally, the extended conformation of the γ-
phosphate is the common orientation observed in crystal structures of other enzymes from the 
ATP-grasp superfamily such as D-Ala:D-Ala ligase, glutathione synthetase, carbamoyl 
phosphate synthetase, and the BC domain of pyruvate carboxylase when bound to ATP analogs 
(Mochalkin et al., 2008). 
18 
 
 
Figure 1.7 Binding of ATP analogs to biotin carboxylase. The N-terminal domain, B-domain, and C-terminal domain are shown in 
transparent yellow, purple, and blue, respectively. Residues are numbered to match the organism described in the figure. Black dashes 
indicate potential hydrogen bonds. Atom colors are: carbon, white (side chains and backbones of residues are colored to match the BC 
domain to which they correspond); nitrogen, blue; oxygen, red; phosphate, orange; fluoride, cyan and Mg
2+
, grey spheres. A) E. coli 
BC bound to AMPPNP in a curled unproductive conformation. B) S. aureus BC bound to AMPPNP in an extended conformation 
bound to two Mg
2+
 ions. C) E. coli BC bound to ADPCF2P in an extended conformation. 
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Two equivalents of magnesium are required for the activity of BC (Climent and Rubio, 
1986) as evidenced by the S. aureus structure of BC that was crystallized with AMPPNP 
showing two magnesium ions in the active site (Figure 1.7 B). One of the magnesium ions is 
coordinated to the side chains of Glu274 and Glu288 and to the α- and γ-phosphate oxygens 
(Mochalkin et al., 2008). The second magnesium ion was coordinated to one of the side chain 
oxygens of Glu288 and to oxygen atoms of the β- and γ-phosphates of AMPPNP (Mochalkin et 
al., 2008). 
Biotin Carboxyl Carrier Protein 
 Early purification of BCCP yielded a range of molecular weights that were attributed to 
oligomerization or proteolytic cleavage of the full length protein (Fall and Vagelos, 1972). The 
C-terminal domain of E. coli BCCP has been shown to be easily isolated by proteolytic cleavage 
with subtilisin Carlsberg to create a stable biotinylated protein domain (BCCPsc) (Fall and 
Vagelos, 1973). The C-terminal domain of BCCPs are highly conserved and contain the lysine 
targeted for biotinylation in an AMKM motif that is invariant with few exceptions (Chapman-
Smith and Cronan, 1999a). Later, Chapman-Smith et al. (1994) developed a system to 
overexpress and purify the last 87 residues of BCCP (BCCP87). BCCP87 can be biotinylated 
and has been shown to have an 8000-fold and 2000-fold greater catalytic efficiency than biotin in 
the BC and CT reactions, respectively (Blanchard et al., 1999a). 
The crystal structure of the C-terminal domain of biotin carboxyl carrier protein from E. 
coli was solved by Athappilly and Hendrickson (1995) (Figure 1.8) and an NMR structure was 
solved shortly after by Yao et al. (1997). The C-terminal domain comprises the last 79 residues 
of the 156 amino acid protein and contains a β-sandwich structure of two four-stranded 
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antiparallel β-sheets (Athappilly and Hendrickson, 1995). The AMKM motif containing Lys122 
is biotinylated and was found in a β-hairpin turn that extends out from the body of the C-terminal 
domain (Chapman-Smith and Cronan, 1999a). In comparison, the C-terminal domains of the 
1.3S subunit of transcarboxylase from P. shermanii (Reddy et al., 1998) and the BCCP domain 
of human ACC2 (Lee et al., 2008) superimposed over the Cα atoms of the crystal structure from 
E. coli with RMSDs of 1.53 and 1.60 Å, respectively. The major difference between the 
structures was the lack of a “thumb” or short loop of about eight amino acids that projects away 
from the body of the C-terminal domain in E. coli BCCP (Figure 1.9) (Cronan, 2001). 
The role of the “thumb” of E. coli BCCP is still unknown but it is thought to interact with 
the biotin moiety and to be involved in protein-protein interactions (Cronan, 2001). The thumb is 
unlikely to be involved in the biotinylation reaction because the BPL from E. coli will biotinylate 
proteins that lack a thumb (Chapman-Smith and Cronan, 1999b). The thumb region of BCCP 
was shown to be essential for growth and function because expressing BCCP mutants with a 
deleted thumb region or replacing the thumb with an alanine, prevented culture growth (Cronan, 
2001). A crystal structure of biotinylated BCCP showed the biotin moiety curled back and 
hydrogen bonding with the side chain and carboxylate of Thr94 located in the thumb (Athappilly 
and Hendrickson, 1995). The NMR structure of BCCP87 also showed the biotin prosthetic group 
curled back and interacting with residues 95-100 in the thumb region of the protein (Roberts et 
al., 1999). Therefore, the thumb may be involved in immobilization of the biotin in solution. 
The orientation of the residues in the C-terminal domain of BCCP affects efficient use of 
the protein as a substrate. The C-terminal domain is thought to undergo a slight change upon 
biotinylation because the unbiotinylated protein interacts with fluorescein-5-maleimide to form a 
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Figure 1.8 C-terminal domain of the biotin carboxyl carrier protein. β-sandwich structure is 
shown as two sets of four strands in yellow and purple. The biotin moiety attached to lysine 122 
is curled back and interacting with the carbonyl oxygen and side chain hydroxyl of threonine 94. 
Atom colors are: carbon, white; nitrogen, blue; oxygen, red and sulfur, yellow. 
 
thioether bond at the single cysteine, C116, of the BCCP87 protein while the biotinylated BCCP 
resists this modification (Chapman-Smith et al., 1997). The NMR structure of apo- 
(unbiotinylated) and holo- (biotinylated) BCCP87 showed that the side chain packing in 
holoBCCP87 was more favorable than that observed in apoBCCP87 and could be interpreted as 
why the biotinylated C-terminal domain is more stable and resistant to proteolysis (Roberts et al., 
1999). Additionally, mutations of the methionines on either side of Lys122 in E. coli to lysine 
still allowed ~50% biotinylation of the protein in vivo and changing the MKM to KAM or MAK 
abolished biotinylation (Reche et al., 1998). However, changing the methionines flanking the 
lysine in the 1.3S subunit of transcarboxylase still allowed biotinylation but carboxylation of 
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biotin was 0-40% of normal activity (Shenoy et al., 1988). Additionally, ~35 residues on both 
sides of the biotin attachment site are required for biotinylation (Chapman-Smith and Cronan, 
1999a). 
 
Figure 1.9 Superposition of biotin carboxyl carrier protein from E. coli (PDB ID= 1BDO), P. 
shermanii transcarboxylase and BCCP domain of human ACC2. 
 
The N-terminal domain of E. coli BCCP has not been crystallized and was not observed 
in the NMR structures, which is thought to be the result of a pro/ala rich linker region between 
the domains that causes the N-terminal domain to be highly flexible (Cronan, 2002). This 
domain is thought to be involved in interactions between subunits and possibly formation of a 
holo-complex (Li and Cronan, 1992a). Nenortas and Beckett (1996) and Choi-Rhee and Cronan 
(2003) showed that when BCCP was expressed in the presence of BC, these proteins formed a 
stable complex. Furthermore, purification of BCCP was made easier by expression in the 
presence of BC and then separating the BCCP from BC using 2 M urea (Nenortas and Beckett, 
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1996). BCCP alone has a tendency to form large aggregates, which has made it difficult to 
confidently determine the oligomeric state of the protein in solution (Choi-Rhee and Cronan, 
2003; Nenortas and Beckett, 1996). The N-terminal domain appears to be responsible for 
aggregation because sedimentation equilibrium experiments indicated that BCCP87 was a 
monomer in solution while BCCP formed 4-10 mers (Nenortas and Beckett, 1996). Additionally, 
the first 18 residues of the N-terminal domain of the 1.3S subunit of transcarboxylase from P. 
shermanii were shown to be required for formation of a stable complex with the 5S and 12S 
subunits (Shenoy et al., 1993).  
Lastly, rotation about the Cα atom of the biotinylated lysine would allow a maximum ~30 
Å of movement (Figure 1.10) (Huang et al., 2010; St Maurice et al., 2007). However, crystal 
structures of pyruvate carboxylase (St Maurice et al., 2007), propionyl-CoA carboxylase (Huang 
et al., 2010) and 3-methylcrotonyl-CoA carboxylase (Huang et al., 2012) have BC to CT active 
site distances of 75, 55, and 80 Å, respectively. This means that BCCP must translocate to cover 
the extra distance between active sites and evidence of this BCCP domain movement was 
observed in the cryo-electron microscopy structures of human propionyl-CoA carboxylase 
(Huang et al., 2010).  
Carboxyltransferase 
 The carboxyltransferase subunit was the last of the three components of ACC to be 
crystallized. The CT domain from yeast was crystallized first (Zhang et al., 2003) and the crystal 
structures of S. aureus and E. coli CT followed shortly thereafter (Figure 1.11) (Bilder et al., 
2006). The bacterial CTs form an α2β2 heterotetramer and the E. coli and S. aureus CT subunits 
share 52% sequence identity (Bilder et al., 2006). The E. coli α-subunit is composed of 319  
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Figure 1.10 Models of biotinylated lysine and BCCP movement in biotin-dependent 
carboxylases. A) “swinging arm” model where the 16 Å biotinylated lysine rotates freely on a 
fixed biotin carboxyl carrier protein. This model would allow about 30 Å of total movement. B) 
“translocation” model where the C-terminal domain of BCCP moves freely between active sites 
via the pro/ala rich linker region while the N-terminal domain interacts with BC and CT. 
 
amino acids and the β-subunit contains 304 amino acids (Bilder et al., 2006). Both the α- and β-
subunits are made up of a core of repeating β-β-α motifs and the N-terminus of the β-subunit 
contains a C4 zinc finger (Waldrop et al., 2012). The two active sites are formed where the α- 
and β-subunits come together at two 9000 Å2 interfaces on opposite sides of the promoter (Bilder 
et al., 2006). The α-subunit of carboxyltransferase binds biotin and the β-subunit binds acetyl-
CoA (Bilder et al., 2006). 
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Figure 1.11 Cartoon representation of the carboxyltransferase subunit of E. coli.  
 
The symmetrical core folds of the α- and β-subunits were shown to belong to the 
crotonase superfamily of enzymes (Figure 1.12) (Bilder et al., 2006). Crotonase folds are used to 
stabilize an enolate anion via an oxyanion hole (Hamed et al., 2008). The oxyanion hole is 
formed from two peptidic NH groups located at the N-terminus of an α-helix to putatively use 
the helix dipole for better stabilization of the anion (Figure 1.12) (Waldrop et al., 2012). The 
conserved active site residues that putatively form the oxyanion holes in E. coli CT are Gly206 
and 207 in the α-subunit and Gly204 and 205 in the β-subunit (Figure 1.12) (Bilder et al., 2006). 
The similar folds in the α- and β-subunits of CT likely arose from an early evolutionary gene 
duplication event that gave rise to similar functions for the two proteins (Waldrop, 2011). The 
purpose of the similar folds of the domains becomes clear after consideration of the catalytic 
mechanism of carboxyltransferase. The reaction necessitates that a proton be removed from
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Figure 1.12 The crotonase folds and active site of the α- and β-subunits of E. coli carboxyltransferase. 
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acetyl-CoA to form an enolate anion. The base for removal of the proton is currently unknown. It 
could be that an active site glutamate is what removes the proton as observed in the other 
crotonase family enzymes (Hamed et al., 2008), or once biotin is decarboxylated, the imidate 
anion of biotin could abstract the proton (Waldrop et al., 2012). Both scenarios allow for the 
nucleophilic attack of the enolate on the carbon atom of CO2. The crotonase fold of the α- and β-
subunits is required to stabilize the imidate and enolate forms of biotin and the acetyl-CoA 
substrates, respectively (Figure 1.13) (Waldrop, 2011). 
 
Figure 1.13 A proposed mechanism of the E. coli carboxyltransferase reaction. 
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 The two subunits of bacterial CT are fused together as two domains on the same 
polypeptide in yeast, the 12S subunit of transcarboxylase from P. shermanii, the β-subunit of 
Roseobacter denitrificans propionyl-CoA carboxylase (Huang et al., 2010), and the β-subunit of 
P. aeruginosa 3-methylcrotonyl-CoA carboxylase (Huang et al., 2012), and each domain of 
these enzymes also contains the crotonase fold (Waldrop et al., 2012). In these multidomain 
proteins, the N-terminal domain binds the acyl-CoA substrate and the C-terminal domain binds 
to biotin (Waldrop et al., 2012). The active sites are formed in a head to tail fashion with the N-
terminal domain interacting with the C-terminal domain of a neighboring subunit (Waldrop et 
al., 2012). Yeast CT comes together to form a dimer (Zhang et al., 2003). In contrast, the β-
subunits of propionyl-CoA carboxylase (Huang et al., 2010) and 3-methylcrotonyl-CoA (Huang 
et al., 2012) carboxylase and the 12S subunit of transcarboxylase (Waldrop et al., 2012) form N- 
to C-terminal timers of dimers, which is common in the crotonase superfamily (Hamed et al., 
2008). 
 The major difference between the bacterial and plant chloroplast multisubunit 
carboxyltransferases and homologous carboxyltransferases from other organisms is the presence 
of the C4 zinc finger observed in the former (Figure 1.14) (Bilder et al., 2006). A common 
function of zinc fingers is to bind nucleic acids. The CT from E. coli was shown to bind DNA 
non-specifically as well as the DNA analog heparin (Benson et al., 2008). Shortly after, CT was 
shown to specifically bind mRNA coding for the α- and β-subunits of CT (Meades et al., 2010). 
Furthermore, the binding of acetyl-CoA and mRNA was shown to be mutually exclusive and 
mutation of the zinc domain cysteines abolished nucleic acid binding and catalytic activity 
(Meades et al., 2010).  
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Figure 1.14 The zinc domain of the carboxyltransferase subunit from E. coli. 
 
Regulation of Acetyl-CoA Carboxylase 
Prokaryotic 
 Acetyl-CoA carboxylase has been shown to be the rate-limiting and committed step in 
fatty acid biosynthesis and is therefore ideal for regulation of this pathway (Davis et al., 2000). 
Fatty acid synthesis accounts for 94% of the ATP consumed in membrane biogenesis and 
therefore inefficient regulation of this pathway would result in a detrimental waste of cellular 
energy (Li and Cronan, 1993). Furthermore using northern blot analysis, it has been shown that 
there is a direct correlation between culture growth rate and mRNA expression of the ACC genes 
in E. coli (Li and Cronan, 1993) and the ratio of the levels of growth rate to transcription of the 
accBC gene in the Gram-positive organism Bacillus subtilis are similar (Marini et al., 2001). 
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The four ACC genes may be transcriptionally regulated. Overexpression of BCCP was 
shown to reduce accBC transcript levels by 90% 40 min after induction compared to uninduced 
levels (James and Cronan, 2004). The overexpression of the first 44 residues of the N-terminal 
domain of BCCP decreases mRNA transcripts by 54% in 30 min and 96% by 60 min (James and 
Cronan, 2004). Additionally, James and Cronan (2004) replaced the promoter of the accBC mini-
operon with the promoter from the lactose operon. Transcription of the accBC gene with the 
lactose promoter increased 4.5-5 fold in comparison to transcription in the presence of the wild-
type promoter (James and Cronan, 2004). The authors concluded that BCCP autoregulates the 
transcription of the accBC operon (James and Cronan, 2004). This is likely the method of 
regulation in many bacterial species because the cotranscription of these two genes is highly 
conserved (James and Cronan, 2004). In contrast, the accA and accD genes encoding the α- and 
β-subunits of CT, respectively, are expressed in gene clusters on opposite sides of the E. coli 
chromosome (Li and Cronan, 1993). For instance, the gene for the α-subunit of 
carboxyltransferase begins within the coding sequence of the polC gene encoding the catalytic 
subunit of DNA polymerase III (Li and Cronan, 1992b). Both genes are transcribed in a 
clockwise rotation and could be coregulated; however, there is no evidence to support this 
hypothesis (Li and Cronan, 1992a, 1993). 
Recently, CT has been shown to regulate its own translation by specifically binding the 
mRNA coding for α- and β-CT subunits (Meades et al., 2010). Acetyl-CoA competes with 
mRNA for the active site of CT (Meades et al., 2010). This allows CT to work as a “dimmer 
switch” for its own translation by sensing the cellular levels of acetyl-CoA (Meades et al., 2010). 
Therefore, when cellular growth rate increases and the intracellular levels of acetyl-CoA are 
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high, CT is displaced from its mRNA allowing the production of malonyl-CoA and translation of 
CT (Figure 1.15) (Meades et al., 2010).  
  The end product of fatty acid synthesis, acylated acyl carrier protein, is a negative 
feedback inhibitor of ACC (Davis and Cronan, 2001). These authors showed that 40 μM of acyl-
ACP (the acyl group being 6 to 20 carbon units) inhibits ACC activity up to 70% (Davis and 
Cronan, 2001).  
 
Figure 1.15 Regulation of bacterial carboxyltransferase activity and translation. (Figure taken 
from Meades et al. (2010)) 
 
Eukaryotic 
 Both isoforms of eukaryotic ACC have been shown to be similarly controlled at the 
transcriptional level. For example, human ACC1 has three promoters (PI, PII and PIII). The PI 
promoter is constitutively active to provide basal levels of fatty acid synthesis (Mao et al., 2003). 
Several transcription factors are involved in activating transcription of the gene from the PII 
promoter, the most notably being sterol regulatory-element binding protein (SREBP), 
carbohydrate response element binding protein, and triiodothyronine (T3 or a thyroid hormone) 
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(Mao et al., 2003; Tong, 2005). In cell lines transfected with each ACC1 promoter upstream of a 
luciferase reporter gene, only PII was shown to be activated by SREBP-1a (one of three isoforms 
of SREBP), which was indicated by a 2.5- to 4-fold increase in luciferase activity (Mao et al., 
2003). T3 had a similar effect on only the PII promoter and luciferase activity was increased 78-
fold (Mao et al., 2003). The PIII promoter is expressed in lactating and cancerous mammary 
glands (Mao et al., 2003). This tissue specific transcription allows for expression of ACC in cells 
that require the production of lipids for neonatal development (Mao et al., 2003). 
 Before covering activation and post-translational modifications of ACC1 and ACC2, it is 
important to understand the physiological role of ACC2. The main difference between ACC1 
and ACC2 is the longer N-terminal region of ACC2, which allows this protein to anchor to the 
outer membrane of the mitochondria (Abu-Elheiga et al., 2000). ACC2 colocalizes to the outer 
membrane of the mitochondria on the cytoplasmic side in proximity to the carnitine 
palmitoyltransferase I (CPTI), which transports acyl-CoAs into the mitochondria for β-oxidation 
(Abu-Elheiga et al., 2000; Kim, 1997). CPTI is inhibited by malonyl-CoA in the nanomolar 
range and when ACC2 is inactivated, β-oxidation is initiated to restore cellular energy levels 
(Kim, 1997; Tong, 2005; Wakil and Abu-Elheiga, 2009). 
The ACC1 and ACC2 isoforms are allosterically regulated by citrate, isocitrate, 
malonate, sulfate and phosphate (Tong, 2005; Zu et al., 2013). Citrate is an allosteric activator of 
ACC (Ka ~ 2mM) and causes polymerization of the mammalian enzyme resulting in 10-20 ACC 
dimers associating to form an 8000 kDa complex (Tong, 2005). In S. cerevisiae citrate activates 
the homotetrameric enzyme but does not cause polymerization and in contrast, citrate does not 
activate ACC in the yeast Schizosaccharomyces pombe (Tong, 2005). Lastly, similar to the 
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bacterial ACCs, mammalian ACC1 and ACC2 exhibited negative feedback inhibition by long-
chain acyl-CoAs from the end of fatty acid synthesis (Munday, 2002). 
Both ACC1 and ACC2 can be post-translationally modified by phosphorylation. ACC1 
and ACC2 are deactivated when phosphorylated by AMP-activated kinase (AMPK) (Kim, 
1997). AMPK phosphorylates serines 79, 1200, and 1215 in ACC1 and 218 in ACC2 resulting in 
an 80% decrease in Vmax (Munday, 2002). Phosphorylation of Ser79 and Ser218 may be the sites 
of the modifications that are necessary to deactivate the enzymes due to the fact that ACC2 does 
not have homologous serine 1200 or 1215 phosphorylation sites (Tong, 2005). AMPK is 
activated by a variety of stress signals and exercise which ultimately shuts down fatty acid 
synthesis and initiates β-oxidation of fatty acids (Tong, 2005). Protein kinase A (PKA) 
phosphorylates serine 77 in ACC1 and ACC2 as well as 1200 in ACC1 but the purpose of this 
covalent modification is not well understood (Zu et al., 2013). The literature on this subject 
matter varies, but phosphorylation of ACC at these sites appears to result in a ~15% decrease in 
the Vmax of the enzyme (Munday, 2002). The decreases in Vmax probably result from 
phosphorylation of serine 77 or 79. Studies using PKA or AMPK to phosphorylate their 
respective serines showed the expected decrease in activity of ACC (Davies et al., 1990). 
Removal of the N-terminal serine 77 and 79 from rat liver ACC using trypsin after incubation 
with PKA or AMPK increased the Vmax of phosphorylated ACC 1.5-fold and 3.5-fold, 
respectively (Davies et al., 1990). Furthermore, the PIII promoter transcribes an ACC1 that is 
lacking the N-terminal phosphorylation sites and this enzyme is thought to be constitutively 
active (Tong, 2005). 
The mechanisms for activation and deactivation of ACC work against each other to 
control fatty acid synthesis and β-oxidation in the cell. Citrate has a reduced affinity for ACC 
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when it is phosphorylated and protects ACC from phosphorylation through polymerization 
(Munday, 2002). Ultimately, regulation at the protein level allows activation of ACC when 
nutrients are high leading to higher concentrations of acetyl-CoA, citrate and ATP; however, 
activities leading to depletion of cellular energy and increased AMP, like exercise, activate 
AMPK and deactivate ACC, initiating β-oxidation of fatty acids (Wakil and Abu-Elheiga, 2009).  
Antibiotic Resistance and Acetyl-CoA Carboxylase as a Target for Antibiotics 
Background 
 Antibiotic resistance is a growing problem worldwide. Pathogenic and non-pathogenic 
bacteria are both problematic because some resistance mechanisms can be transferred between 
microorganisms (Gilchrist et al., 2007; Gould, 2009). Overprescription and non-therapeutic use 
of antibiotics (i.e. routine addition of antibiotics to feeding and procedures in the livestock 
industry) are two of the main causes of rising resistance and reversing the practices we are 
entrenched in remains a problem (Gilchrist et al., 2007; Gould, 2009). Furthermore, the 
production of new and novel antibiotics is not keeping up with resistance and threatens to render 
our current arsenal of antibiotics ineffective (Costelloe et al., 2010; Gould, 2009; Katz et al., 
2006).  
Fatty Acid Synthesis as an Antibiotic Target 
 Triclosan or 2,4,4′-trichloro-2′-hydroxy-diphenyl ether epitomizes the misuse of 
antibiotics as well as validates the enzymes of fatty acid synthesis as a viable antibiotic target 
(Figure 1.16, 1) (Schweizer, 2001). Triclosan is the active ingredient in antibacterial products 
including soap, toothpaste, cosmetics and is infused in children’s toys, bedding, clothes and other 
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Figure 1.16 Inhibitors of enzymes involved in type II fatty acid synthesis. 1 enoyl-ACP reductase 
inhibitor. 2 and 3 are pyrrolidinedione inhibitors of carboxyltransferase. 4 and 5 are 
pyridopyrimidine inhibitors of biotin carboxylase. 6-8 are aminooxazole inhibitors of biotin 
carboxylase. 
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common household items. Triclosan inhibits enoyl-ACP reductase (EAR), an enzyme involved 
in fatty acid synthesis downstream of ACC, within the picomolar range (Schweizer, 2001). 
However, the excessive overuse of this antibiotic has contributed to several mechanisms of 
resistance, which include mutations in EAR, increased expression of EAR, efflux pumps to expel 
the molecule from the organism and degradation of the molecule (Schweizer, 2001). Therefore, 
new antibiotic targets are required. 
Targeting the Carboxyltransferase Active Site 
 Acetyl-CoA carboxylase was validated as an antibiotic target when Freiberg et al. (2004) 
demonstrated that pseudopeptide pyrrolidinediones, such as moiramide B and andrimid, inhibit 
the carboxyltransferase subunit of bacterial ACC with nanomolar affinity (Figure 1.16, 2 and 3). 
These compounds were shown to effectively inhibit the CT subunit of Gram-negative and Gram-
positive microorganisms including E. coli, P. aeruginosa, B. subtilis, S. aureus, and 
Streptococcus pneumoniae while not inhibiting the human isoform of the enzyme (Freiberg et 
al., 2004; Freiberg et al., 2006). Kinetic analysis showed that the natural products moiramide B 
and andrimid are competitive inhibitors versus malonyl-CoA (Freiberg et al., 2004). However, 
there are currently no structures of bacterial CT in complex with inhibitors or substrates and 
these structures are desperately needed to continue development of CT as an antibiotic target. 
Targeting the Biotin Carboxylase Active Site 
 Scientists at Pfizer described the first class of compounds with antibiotic activity 
targeting the biotin carboxylase subunit by using whole bacterial-cell screening with a compound 
library originally made to target eukaryotic protein kinases (Miller et al., 2009). 
Pyridopyrimidine compounds, such as 4 and 5 in Figure 1.16, exhibited potent antibacterial 
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activity against several human pathogens (Miller et al., 2009). Mutations responsible for 
resistance to high concentrations of the pyridopyrimidine compounds were mapped to the gene  
 
Figure 1.17 Overlays of inhibitors bound to E. coli biotin carboxylase. Structures of E. coli BC 
bound to inhibitors with antibiotic properties are shown superimposed over E. coli BC bound to 
AMPPCF2P. The structure bound to the ATP analog is shown with the N-terminal domain, B-
domain, and C-terminal domain as well as their corresponding residues represented as sticks in 
yellow, purple, and blue, respectively. The residues are represented in their single letter 
abbreviation and their sequence number in E. coli BC. Atom colors are: carbon, white or dark 
grey (side chains and backbones of residues are colored to match the BC domain to which they 
correspond); nitrogen, blue; oxygen, red; phosphate, orange; fluoride, cyan and bromine, dark 
red. Hydrogen bonding interactions are shown as dashed lines. A) Shows compound 4 bound to 
BC (in white transparency) overlaid onto BC bound to AMPPCF2P. B) Shows the structures of 
BC bound to compound 6 and compound 7 overlaid on BC bound to AMPPCF2P. The ATP 
analog has been removed for clarity and compound 6 is shown with dark grey carbons to 
differentiate it from compound 7 shown with white carbons. The cartoon ribbons of BC match 
their ligand carbon color. 
 
encoding the BC subunit of ACC. The pyridopyrimidine hits were found to inhibit BC with an 
IC50 in the nanomolar range (Miller et al., 2009). Furthermore, the compounds show selectivity 
for BC over 30 other eukaryotic protein kinases and rat liver ACC. Finally, several crystal 
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structures of BC in complex with pyridopyrimidines have been solved. Cocrystallization of 
compound 4 with BC showed that it bound to the ATP site (Figure 1.17 A) (Miller et al., 2009). 
Compound 4 was used as a template in ligand-based virtual screening to identify new 
inhibitors of BC. These compounds, such as 6, had similar pharmacophore features and 
antimicrobial properties to the pyridopyrimidines (i.e. special arrangement of functional groups) 
(Mochalkin et al., 2009). Compound 6 contained an exo-cyclic amino group in the oxazole ring 
and had an IC50 for BC in the micromolar range (Figure 1.16, 6) (Mochalkin et al., 2009). A 
subsequent crystal structure of BC bound to compound 6 showed that it bound the ATP site 
similar to compound 4. Using fragment-based drug design, Mochalkin et al. (2009) optimized 
binding interactions of the inhibitor with BC and extended the original scaffold of compound 6 
into a hydrophobic pocket near the ribose binding region of the ATP site. This approach yielded 
derivatives from compound 6 such as compound 7 and compound 8 that had 200- and 3000-fold 
more potent IC50 values for BC than compound 6 (Figure 1.16, 7 and 8) (Figure 1.17 B) 
(Mochalkin et al., 2009).  
The Future of New Antibiotic Targets 
 Despite efforts over the last couple of years, there are currently no antibiotics in clinical 
use that target ACC. Even worse, pharmaceutical company’s interest in pursuing profitable drug 
development has created an insufficient level of antibiotic research (Table 1.1) (Katz et al., 
2006). However, this provides an opportunity for academic researchers to pick up where the 
pharmaceutical companies left off. Determining new antibiotic targets and bringing existing 
inhibitors closer to being clinically useful could create incentive for these companies to rejoin the 
fight against drug resistant pathogens. Development of antibiotics could stop microorganisms 
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like M. tuberculosis which cause an estimated 8 million new infections and 2 million deaths 
worldwide each year (Lin et al., 2006). 
Table 1.1 Antibiotic development at select pharmaceutical companies in 2006* 
Company New antibiotic 
approved for 
use since 1998 
in 2006 
Number of 
antibiotics in 
phase 2 trials 
or beyond in 
2006 
Approximation of 
total drugs in 
phase 2 trials or 
beyond in 2006 
Pfizer 2 2 16 
Merck & Co. 1 1 26 
Johnson & Johnson 0 1 18 
GlaxoSmithKline 0 1 34 
Bristol-Myers Squibb 0 0 8 
Novartis 0 0 41 
Bayer 0 0 4 
        *The data in Table 1.1 was reconstructed from Katz et al. (2006). 
 
Purpose of Dissertation 
 Despite over 50 years of research on E. coli acetyl-CoA carboxylase, it has never been 
established if the three components, biotin carboxylase, biotin carboxyl carrier protein, and 
carboxyltransferase work in isolation or come together to form a macromolecular complex. 
Furthermore, there has never been a three-dimensional structure of acetyl-CoA carboxylase or 
biotin carboxyl carrier protein bound to BC or CT. The focus of this dissertation is to determine 
if the individual components of acetyl-CoA carboxylase form a complex, and if the complex 
formation plays a role in regulation of enzyme activity. Chapter 2 describes complex formation 
of E. coli acetyl-CoA carboxylase using enzyme kinetic, co-immunoprecipitation or pull-down 
assays, and in vivo cooverexpression of all three components. Chapter 3 describes the first 
complex of biotin carboxylase and biotin carboxyl carrier protein subunits of E. coli acetyl-CoA 
carboxylase to a 2.49 Å resolution. 
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CHAPTER 2 
COMPLEX FORMATION AND REGULATION OF ESCHERICHIA COLI ACETYL-
COA CARBOXYLASE 
 
Introduction 
Fatty acid biosynthesis is one of the most important and fundamental metabolic pathways 
in nature. Animals use fatty acids as a component of cellular membranes and for energy storage, 
while bacteria only use fatty acids for membrane biogenesis (Zhang and Rock, 2008). Thus, 
regulation of fatty acid biosynthesis is critical to the survival of organisms from bacteria to 
humans. Fatty acid synthesis in bacteria is commonly referred to as fatty acid synthesis II (FAS 
II) to distinguish it from the eukaryotic pathway, which is designated fatty acid synthesis I (FAS 
I). FAS II is distinguished from FAS I by the fact that all of the enzymes in the pathway are 
separate proteins whereas in FAS I, the enzymes constitute domains on a single polypeptide 
(Rock and Cronan, 1996). The major regulatory enzyme in bacterial fatty acid biosynthesis is 
acetyl-CoA carboxylase (ACC), which catalyzes the committed step in this pathway (Cronan and 
Waldrop, 2002). 
Acetyl-CoA carboxylase catalyzes the biotin-dependent carboxylation of acetyl-CoA to 
form malonyl-CoA via two half-reactions (Scheme 2.1). In Escherichia coli and many other 
Gram-negative and Gram-positive bacteria, the enzyme consists of three different components: 
biotin carboxylase (BC), biotin carboxyl carrier protein (BCCP), and carboxyltransferase (CT). 
In the first half-reaction, biotin carboxylase catalyzes the formation of a reactive 
carboxyphosphate intermediate through the ATP-dependent phosphorylation of bicarbonate 
(Knowles, 1989). The carboxyl group is transferred from carboxyphosphate to the vitamin biotin, 
which in vivo is covalently attached to BCCP (Athappilly and Hendrickson, 1995; Chapman-
Smith and Cronan, 1999). In the second half-reaction, carboxyltransferase transfers the carboxyl 
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group from carboxybiotin to acetyl-CoA to make malonyl-CoA (Blanchard and Waldrop, 1998; 
Polakis et al., 1974). 
 
Scheme 2.1 Acetyl-CoA carboxylase half-reactions and sum. 
 
While E. coli acetyl-CoA carboxylase consists of three different proteins, four different 
gene products are required to make the functional enzyme. The biotin carboxylase component is 
a homodimer with a monomer molecular weight of 49.4 kDa and is encoded by the accC gene. 
The BCCP component is a 16.7 kDa polypeptide that has been reported to form higher molecular 
weight aggregates and is encoded by the accB gene (Li and Cronan, 1992a; Nenortas and 
Beckett, 1996). The carboxyltransferase component is an α2β2 heterotetramer with a 35.1 kDa α-
subunit encoded by accA and a 33.2 kDa β-subunit encoded by accD (Li and Cronan, 1992b). 
Acetyl-CoA carboxylase (like all biotin-dependent carboxylases) is considered to have a 
non-classical or two-site ping-pong kinetic mechanism, which means the active sites for biotin 
carboxylase and carboxyltransferase are separate and do not interact or communicate with one 
another (Cook and Cleland, 2007). This type of kinetic mechanism is consistent with the fact that 
when either the carboxylase or transferase components of E. coli acetyl-CoA carboxylase are 
isolated, they retain their enzymatic activity (Guchhait et al., 1974). This observation has led to 
two hypotheses for the mechanism of action for the enzyme. One theory posits that after BCCP 
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is carboxylated by biotin carboxylase, it dissociates and undergoes diffusion until it binds to 
carboxyltransferase. Alternatively, the second theory suggests that all the components of acetyl-
CoA carboxylase form a complex where the flexible region of BCCP alternates between the 
active sites of biotin carboxylase and carboxyltransferase (Cronan and Waldrop, 2002). The 
latter mechanism involves extensive protein-protein interactions (PPI). Since PPI are well known 
to play significant roles in the regulation of many cellular processes such as binding of hormones 
to cell surface receptors, signal transduction, and allosteric regulation of enzymes, PPI may also 
play a role in the regulation of acetyl-CoA carboxylase activity (Ozbabacan et al., 2011; Perkins 
et al., 2010). 
Understanding the regulation of bacterial acetyl-CoA carboxylase activity has become 
more pressing because of recent findings. It was recently proposed that during stationary phase 
when acetyl-CoA levels are low, carboxyltransferase binds to the mRNA coding for the α- and β-
subunits of the enzyme resulting in inhibition of both catalysis and translation of the mRNA. 
When acetyl-CoA levels are high, such as in the log phase of E. coli growth, acetyl-CoA 
competes with the mRNA coding for the α- and β-subunits of carboxyltransferase thereby 
allowing catalysis and translation to continue (Meades et al., 2010). Thus, carboxyltransferase 
acts as a “dimmer” switch to regulate its own enzymatic activity and gene expression at the level 
of translation. 
This leaves the question, how is the activity of biotin carboxylase regulated when 
carboxyltransferase is bound to its mRNA? Most importantly, does biotin carboxylase 
continuously carboxylate biotin and hydrolyze ATP or is the activity decreased when 
carboxyltransferase is sequestered away bound to its mRNA? In this report, these questions are 
answered by demonstrating that all of the components of acetyl-CoA carboxylase form a 
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multiprotein complex where the protein-protein interactions play an integral part in regulating 
the activity of the enzyme. 
Experimental Procedures 
Reagents 
Amicon Ultra Centrifugal Filters MW cutoff 10,000 were from Millipore. M280 
streptavidin Dynabeads were from Invitrogen. Bradford protein assay reagent, Opti-4CN 
substrate kit, gel filtration standards, goat anti-mouse IgG (H+L)-HRP conjugate, and avidin-
HRP conjugate were purchased from Bio-Rad. Expression vectors, Perfect Protein Marker, Nova 
Blue competent cells, and BL21(DE3) competent cells were obtained from Novagen. 
Kanamycin, streptomycin, IPTG, and PINKstain Protein Ladder were from Gold Biotechnology. 
Restriction endonucleases, T4 DNA ligase, and dNTPs were purchased from New England 
Biolabs. Pfu UltraII fusion was from Agilent. FLAG octapeptide was synthesized by Chi 
Scientific. BioTrace PVDF Membrane was from PALL Life Sciences. THE His-Tag Antibody 
Anti-His monoclonal antibody from mouse was purchased from GenScript. Casamino acids were 
from Lab Scientific. Deuterium oxide was from Acros. All primers (Table 2.1) were synthesized 
by Eurofins MWG Operon. HiLoad 16/60 Superdex 200 prepgrade gel filtration column was 
from Amersham Biosciences, while HisTrap HP Ni Sepharose columns were from GE 
Healthcare. All other reagents were from Sigma/Aldrich. 
The 2-aminooxazole dibenzylamide inhibitor of biotin carboxylase was synthesized 
according to Mochalkin et al. (2009). The carboxyltransferase inhibitor, andrimid was a gift from 
Pfizer. To measure the deuterium kinetic isotope effect on acetyl-CoA carboxylase, D3-acetyl-
CoA was synthesized by a modification of the procedure by Simon and Shemin (1953). First, in 
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a 25 mL flask, 40 mg of the trilithium salt of coenzyme A was dissolved in 3 mL of 1M 
triethylammonium bicarbonate. Next, 5 g of D6-acetic anhydride was added to the coenzyme A 
solution dropwise with mixing. Once all the D6-acetic anhydride was added, the mixture was left 
on ice for 45 min, with periodic mixing. The reaction mixture was then allowed to warm to room 
temperature over the course of an hour. Then 1 mL of water and 3 drops of glacial acetic acid 
were added to the solution. The mixture stood at room temperature overnight. The following day, 
the reaction was lyophilized to dryness, and the powder was resuspended in water. The 
concentration of D3-acetyl-CoA was determined spectrophotometrically at 260 nm using the 
extinction coefficient of 16,800 M
-1
 cm
-1
 for coenzyme A. 
Table 2.1 Primers for Expression Plasmid Construction 
Primer  DNA sequence* Plasmid Enzyme 
FlagBC5  (5’ –CTTCTTCATATGGATTATAAAGACGATGACGATAAAATGCTGGATAAAATTGTTATT) pAEP4 FLAG-BC 
FlagBC3  (5’ –CTTCTTTTAATTAATTATTTTTCCTGAAGACCGAG) 
  
BCCP5  (5’ –CTTCTTCATATGGATATTCGTAAGATTAAAAAA) pAEP3 BCCP-BC 
BCCP3  (5’ –CTTCTTGGATCCACCTCCTTACTCGATGACGACCAGCGGCTC) 
  
BC5  (5’ –CTTCTTGGATCCGATGCTGGATAAAATTGTTATTGCC) pAEP7 
 
BC3  (5’ –CTTCTTCTCGAGTTATTTTTCCTGAAGAACGAG) 
  
FlagCTa5  (5’ –CTTCTTCCATGGACTACAAAGACGATGACGATAAAATGAGTCTGAATTTCCTTGAT) pMEP1 FLAG-CT 
FlagCTb3  (5’ –CTTCTTGGATCCTCAGGCCTCAGGTTCCTGATC) 
  * The underlined nucleotides indicate a restriction endonuclease cut site. The bold nucleotides 
indicate a FLAG-tag coding sequence. 
 
Expression Vector Construction 
The plasmid coding for biotin carboxylase with an N-terminal FLAG-tag (FLAG-BC) 
was produced by amplifying the accC gene using the primers FlagBC5 and FlagBC3 (Table 2.1) 
and pGLW1 as a template (Blanchard et al., 1999b). The primers allowed for the introduction of 
both an NdeI site and the sequence coding for the FLAG-tag on the 5′ end of the gene along with 
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a PacI site on the 3′ end. The PCR product was cut with NdeI and PacI and ligated into 
pETDuet-1 cut with the same enzymes to create pAEP4. 
The plasmid coding for carboxyltransferase with an N-terminal FLAG-tag on the α-
subunit (FLAG-CT) was constructed by amplifying the accA and accD genes using pCZB3 as a 
template. The plasmid pCZB3 contains the genes coding for the α- and β-subunits of 
carboxyltransferase in a minioperon (Blanchard and Waldrop, 1998). Primers FlagCTa5 and 
FlagCTb3 (Table 2.1) introduced both an NcoI site and the sequence coding for the FLAG-tag on 
the 5′ end of the accA gene and a BamHI site on the 3′ end of the accD gene. The PCR product 
was cut with NcoI and BamHI and ligated into pCDFDuet-1 cut with the same enzymes to create 
pMEP1. 
A minioperon of the accB and accC genes was constructed to generate the biotin 
carboxyl carrier protein – biotin carboxylase complex (BCCP-BC). The BCCP5 and BCCP3 
primers were used to amplify the BCCP gene (accB) using pYML11 as a template. The plasmid 
pYML11 contains the gene for E. coli BCCP in pGEM7 between the EcoRI and BamHI cut sites. 
The primers introduced an NdeI site on the 5′ end of the gene, and both the sequence 5′ –
AAGGAG-3′, which encoded a ribosomal binding site, and a BamHI site were added to the 3′ 
end of the gene. The PCR product was cut with NdeI and BamHI and ligated into pET28b(+) cut 
with the same enzymes to create pAEP3. The accC gene was amplified from pGLW1 using the 
primers BC5 and BC3 to introduce a 5′ BamHI site and a 3′ XhoI site. The resulting PCR product 
was cut with BamHI and XhoI and ligated into pAEP3 cut with the same enzymes to create 
pAEP7. This yielded a plasmid with an accBC minioperon containing a 13 bp intercistronic 
region that expressed an N-terminal His-tagged BCCP and biotin carboxylase. 
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Protein Expression in E. coli 
Biotin carboxylase with a His-tag on the N-terminus (Blanchard et al., 1999b) and 
carboxyltransferase with a His-tag on the N-terminus of the α-subunit (Blanchard and Waldrop, 
1998) was expressed and purified as previously described. Biotinylated BCCP with a His-tag on 
the N-terminus was a gift from Pfizer. 
FLAG-BC was produced by transforming E. coli strain BL21(DE3) with pAEP4 and then 
using a freshly transformed colony to inoculate either 0.5 liters of LB medium in a 2 liter flask or 
1 liter of LB medium in a 2.8 liter Fernbach flask. The LB medium also contained 50 µg/mL of 
ampicillin. The cells were incubated at 37 °C with shaking until mid-log phase. Then 250 µM 
IPTG was added to the culture, which was incubated for another 2.5-3.5 h. The cells were 
harvested by centrifugation and frozen at -20 °C. 
FLAG-CT was produced by transforming E. coli strain BL21(DE3) with pMEP1 and 
then using a freshly transformed colony to inoculate either 0.5 liters of LB medium in a two liter 
flask or 1 liter of LB medium in a 2.8 liter Fernbach flask containing either 10 mL glycerol or 1 
g casamino acids. The LB medium also contained 50 µg/mL of streptomycin. The flasks were 
incubated at 37 °C with shaking until mid-log phase and then allowed to stand and cool to room 
temperature. After the flasks had cooled, one of the following were added to induce expression 
of the gene coding for FLAG-CT: 250µM IPTG, 1 g lactose, or both 250 µM IPTG and 1 g 
lactose. After the addition of IPTG or lactose, flasks were either incubated with shaking for 2.5-
3.5 h at room temperature or they were allowed to stand at room temperature overnight. The cells 
were harvested by centrifugation and frozen at -20 °C. A typical preparation would involve 
several flasks with different various combinations of inducing agent and incubation conditions. 
57 
 
Overexpression of holo-acetyl-CoA carboxylase was accomplished with a two-plasmid 
system where plasmids pAEP7 and pMEP1 were both transformed into E. coli strain 
BL21(DE3). Overexpression was achieved with the same procedure as described above for 
FLAG-CT except that the LB medium contained 50 µg/mL of streptomycin and 30 µg/mL of 
kanamycin. 
Protein Purification 
The first step in protein purification was affinity chromatography using either a nickel-
based resin for proteins with a His-tag or an ANTI-FLAG M2 gel for proteins with a FLAG-tag. 
For proteins with a His-tag, the cell pellets were suspended in equilibration/wash buffer (20 mM 
NaH2PO4, 500 mM NaCl, 15 mM imidazole, pH 7.8) and then were lysed by sonication and 
passage through a French press. Nucleic acids were removed by the addition of DNase. The cell 
lysate was centrifuged at 34540 g for 1 h at 4 °C. The supernatant was loaded onto a nickel 
affinity column pre-equilibrated with equilibration/wash buffer and then washed with ten column 
volumes of the same buffer. Protein was eluted using a segmented gradient starting with eight 
column volumes of 0-10% elution buffer (20 mM NaH2PO4, 500 mM NaCl, 250 mM imidazole, 
pH 7.8), followed by 12 column volumes of 10-100% elution buffer and finally eight column 
volumes of 100% elution buffer. For proteins with a FLAG-tag, the cell pellets were suspended 
in TBS wash (50 mM Tris-HCl, 150 mM NaCl, pH 7.4) and were lysed in the same manner as 
for the His-tagged proteins. After centrifugation, the supernatant was loaded onto a column 
containing ANTI-FLAG M2 affinity gel, and protein was eluted according to the protocol 
provided by the manufacturer (Sigma) of the ANTI-FLAG M2 affinity resin. 
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Protein from either the nickel affinity or anti-FLAG columns was further purified by size 
exclusion chromatography. Protein eluted from either affinity column was dialyzed for 12 h 
against the following buffer: 134 mM KCl, 10 mM KH2PO4, 1 mM EDTA, pH 7.8. The dialysate 
was then dialyzed for 12 h against 10 mM Hepes, 500 mM KCl, pH 7.8 (referred to hereafter as 
2
nd
 dialysis), and then concentrated using Amicon Centrifugal Filters and loaded onto a Hi-Load 
16/60 Superdex 200 column pre-equilibrated with 2
nd
 dialysis. Fractions containing pure protein 
were concentrated and stored at -80 °C. 
Pull-down Assays 
Assays targeting biotinylated-BCCP utilized M-280 streptavidin Dynabeads. A 100 µL 
suspension of beads was washed three times with 100 µL PBS buffer (2.7 mM KCl, 10 mM 
Na2HPO4, 1.76 mM KH2PO4, pH 7.4) as described in the manufacturer’s protocol. Then 50 µL 
of 77.8 µM BCCP was added to the beads and the beads were pelleted using a neodymium 
magnet. The beads were resuspended by gently shaking at 25 °C for 1 h and then pelleted again 
and washed once with PBS buffer. A 450 µL solution of 1.67 mM AMPPNP, 0.7 µM CT, 0.94 
µM BC, 3.2 mM acetyl-CoA, 22.2 mM MgCl2, 22.2 mM potassium bicarbonate, 111.2 mM 
Hepes pH 7.8, and 22.2 mM biotin was added to the pelleted beads, which were resuspended by 
mixing at 25 °C for 45 min. The beads were pelleted with a neodymium magnet and the 
supernatant was removed. The pellet was washed four times with 200 µL, 150 µL, 100 µL and 
90 µL of PBS, and 0.1% Tween-20 (PBST). After the last wash, the pellet was resuspended in 10 
µL SDS-PAGE buffer and 20 µL PBST and incubated at 80 °C for 15 min. The beads were 
pelleted with a neodymium magnet, and the supernatant was removed for Western blot analysis. 
 
59 
 
For pull-down assays targeting FLAG-BC, ANTI-FLAG M2 affinity resin was washed 
three times with 190 µL TBS. A solution of 55 µL TBS and 55 µL 2
nd
 dialysis containing 11.6 
µM FLAG-BC was added to the ANTI-FLAG M2 resin and mixed at 25 °C for 1 h. After 
centrifugation, the supernatant was removed, and a 450 µL solution containing 1.7 mM 
AMPPNP, 0.9 µM CT, 6.9 µM BCCP, 3.2 mM acetyl-CoA, 22.2 mM MgCl2, 22.2 mM 
potassium bicarbonate and 111.2 mM Hepes pH 7.8 was added and mixed at 25 °C for 1.5 h. The 
pellet was washed four times with 200 µL, 150 µL, 100 µL and 90 µL of TBS. After the last 
wash, the pellet was resuspended in 10 µL SDS-PAGE buffer and 20 µL of 500 µg/mL FLAG 
peptide and incubated at 80 °C for 15 min. After centrifugation, the supernatant was removed for 
Western blot analysis. Pull-down assays targeting FLAG-CT were done exactly as described for 
the FLAG-BC pull-down assays with two exceptions. First, 55 µL of a 22 µM FLAG-CT 
solution was added to the washed resin instead of 55 µL of an 11.6 µM FLAG-BC solution. 
Second, the supernatant was removed after 40 min of mixing, and a 445 µL solution of 1.7 mM 
AMPPNP, 0.95 µM BC, 4.0 µM BCCP, 3.3 mM acetyl-CoA, 22.5 mM MgCl2, 22.5 mM 
potassium bicarbonate and 112.5 mM Hepes pH 7.8 was added and mixed at 25 °C for 1 h. 
Western Blot Analysis 
Samples were run on a SDS-PAGE gel and transferred to a PVDF membrane in transfer 
buffer (39 mM glycine, 48 mM Tris, 20% methanol, 0.04% SDS) for 15 h at 60 V. PVDF 
membrane with transferred PINKstain Protein Ladder was washed in TBST (136.9 mM NaCl, 
2.68 mM KCl, 24.8 mM Tris, pH 7.4 with HCl, 0.1% Tween-20) gently shaking at 25 °C for 20 
min. The membrane was then blocked with 18 mL of TBST with 5% dry milk gently shaking at 
25 °C for 1 h. Then a 1:3000 ratio of 1 µg/µL Anti-His monoclonal antibody and anti-FLAG 
antibody from mouse were added to the TBST with 5% dry milk and incubated at 25 °C gently 
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shaking for 1 h. The membrane was washed three times in 20 mL TBST gently shaking at 25 °C 
for 10 min each time and then incubated in 18 mL TBST with 5% dry milk with a 1:4800 ratio of 
1 µg/µL of goat anti-mouse HRP conjugate antibody while gently shaking at 25 °C for 1 h. After 
three more 10 min washes in TBST, the membrane was exposed to the Opti-4CN substrate for 15 
min according to the instructions provided by the manufacturer Bio-Rad. 
Kinetic Assays 
The activity of biotin carboxylase and holo-acetyl-CoA carboxylase was determined 
spectrophotometrically by measuring the production of ADP using pyruvate kinase and lactate 
dehydrogenase and following the oxidation of NADH at 340 nm. Each reaction contained 17.5 
units of lactate dehydrogenase, 10.5 units of pyruvate kinase, 0.5 mM phosphoenolpyruvate, 0.32 
mM NADH, 20 mM MgCl2, 15 mM potassium bicarbonate and 100 mM HEPES at pH 7.8. The 
activity of carboxyltransferase was measured as previously described (Blanchard and Waldrop, 
1998). All reactions were carried out in a total of 0.5 mL in a 1 cm path-length quartz cuvette. 
All reactions were initiated by addition of enzyme and were maintained at 25 °C via a circulating 
water bath. Spectrophotometric data was collected using an Uvikon 810 spectrophotometer 
interfaced to a PC with a data acquisition program. 
Kinetic Analysis 
Data were analyzed by non-linear regression using the computer programs of Cleland 
(Cleland, 1979). Initial velocities obtained by varying one of the substrates (A) were fitted to 
Equation 1 to determine the maximal velocity (V) and the Michaelis constant (Km). 
  
  
( m  )
   (Eq. 1) 
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When one substrate was varied at different fixed levels of another substrate, data were 
fitted to Equation 2 or Equation 3, describing sequential or ping-pong initial velocity patterns, 
respectively. In these equations,   is the experimentally determined velocity, V is the maximal 
velocity, Ka and Kb are the respective Michaelis constants for substrates A and B, and Kia is the 
dissociation constant of A. 
  
   
 iaKb  KaB   KbA   AB
 (Eq. 2) 
  
   
KaB   KbA   AB
  (Eq. 3) 
Data describing noncompetitive inhibition were fitted to Equation 4, where V is the 
maximal velocity, Km is the Michaelis constant, I is the concentration of inhibitor, and Kis and Kii 
are the slope and intercept inhibition constants, respectively. 
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 (Eq. 4) 
Multiple inhibition data were fitted to Equation 5, where KL and KJ are the apparent 
dissociation constants for the two inhibitors and α is a measure of the degree of interaction of the 
two inhibitors. 
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Results 
Bacterial acetyl-CoA carboxylase, and the E. coli form in particular, has been the model 
system for studying biotin-dependent enzymes for two reasons. First, the carboxylase and 
transferase components retain their activity when isolated, and second, both biotin carboxylase 
and carboxyltransferase will utilize free biotin (i.e. biotin not covalently attached to BCCP) as a 
substrate thereby simplifying kinetic analysis (Guchhait et al., 1974). While the use of free biotin 
has allowed for detailed kinetic and mechanistic studies on biotin carboxylase and 
carboxyltransferase, the fact remains that in vivo biotinylated BCCP, not free biotin, is the 
substrate for these two enzymes (Cronan and Waldrop, 2002). However, biotinylated BCCP 
turns out not to be a very good substrate for biotin carboxylase (Figure 2.1). In fact, the rate of 
ATP hydrolysis by biotin carboxylase is low even when all of the components of acetyl-CoA 
carboxylase are present (Figure 2.1). Not until acetyl-CoA is added is a dramatic increase in the 
rate of ATP hydrolysis detected (Figure 2.1). This phenomenon where biotin carboxylase only 
hydrolyzes ATP in the presence of BCCP, carboxyltransferase, and acetyl-CoA was first noted 
by Soriano et al. (2006) and Alves et al. (2011) when these groups were developing high-
throughput screening assays for bacterial acetyl-CoA carboxylase. The results in Figure 2.1 
suggest there is communication between the active sites of biotin carboxylase and 
carboxyltransferase and by inference implies that all of the components form a higher order 
protein complex. The active site communication is an example of substrate synergism where 
enzyme activity is regulated by only allowing ATP to be utilized when acetyl-CoA is present 
thereby preventing wasteful hydrolysis of ATP. 
 
63 
 
 
Figure 2.1 The effect of acetyl-CoA and the different components of acetyl-CoA carboxylase on 
the specific activity of biotin carboxylase. The specific activities were calculated based on the 
amount (16.1 µg) of BC in each reaction. Numbers above the bar indicate the specific activity 
and a ( ) symbol below the bar indicates the presence of either 0.32 μM BC, 0.24 μM CT, 2 μM 
BCCP, and/or 423 μM acetyl-CoA. ATP and bicarbonate were held constant at 0.4 mM and 3.25 
mM, respectively. All reactions were initiated by the addition of BC. 
 
Two distinct experimental approaches were used to address the active site 
communication and whether complex formation is necessary for the regulation of acetyl-CoA 
carboxylase activity. The first approach involved kinetic characterization of acetyl-CoA 
carboxylase, while the second approach used pull-down/co-immunoprecipitation assays to detect 
complex formation both in vitro and in vivo. 
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Kinetic Analysis 
Any kinetic analyses of acetyl-CoA carboxylase must start by noting that the enzyme is 
considered to be a non-classical or two-site ping-pong enzyme (Figure 2.2). If acetyl-CoA 
carboxylase is indeed a two-site ping-pong (a.k.a. double displacement) enzyme, then each of the 
two half-reactions are expected to exhibit activity in the absence of the substrate for the other 
half-reaction. In the case of acetyl-CoA carboxylase, one would expect ATP hydrolysis in the 
absence of acetyl-CoA. However, as has already been pointed out, that does not occur (Figure 
2.1). Conversely, when carboxyltransferase is assayed in the non-physiological direction with 
BCCP and malonyl-CoA as substrate, no activity could be detected in the absence of ATP (data 
not shown). This lack of reversibility is in stark contrast to isolated carboxyltransferase which is 
routinely assayed in the reverse direction (Blanchard and Waldrop, 1998). Thus, not only do the 
two half-reactions not exhibit independent activity as expected of a ping-pong enzyme, but also 
the fact that the reaction is irreversible in acetyl-CoA carboxylase but not in isolated 
carboxyltransferase strongly suggests the individual components form a complex. 
Isotope Effects 
In the second half-reaction, the carboxyl group on carboxybiotin is transferred to acetyl-
CoA. For the carboxylation reaction to occur, a proton must be removed from the methyl group 
of acetyl-CoA. This allows the kinetic isotope effect for substituting deuterium for hydrogen in 
the methyl group of acetyl-CoA to be determined. If acetyl-CoA carboxylase has a conventional 
ping-pong kinetic mechanism, then the isotope effect when ATP is varied, 
D
(V/KATP), should be 
unity because the first half-reaction catalyzed by biotin carboxylase does not include the isotope 
sensitive step. The 
D
(V/KATP) = 1.62 ± 0.01 while the isotope effect on the maximal velocity 
D
V 
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= 1.8 ± 0.2. The lack of unity for 
D
(V/KATP) is inconsistent with a strict ping-pong mechanism 
and suggests an interaction between the two half-reactions. 
 
Figure 2.2 Kinetic mechanism of acetyl-CoA carboxylase as a two-site ping-pong mechanism. 
 
The kinetic isotope effects also provide insight into the relative rates of the two half-
reactions. For instance, the fact that the isotope effect on the maximal velocity (
D
V) is not equal 
to the intrinsic isotope effect (~6.2)
1 
indicates that the second half-reaction catalyzed by 
carboxyltransferase is not completely rate-limiting. Moreover, because the 
D
V and 
D
(V/Kacetyl-
CoA) are, within error, equal (the 
D
(V/Kacetyl-CoA) = 2.1 ± 0.2), the first half-reaction catalyzed by 
biotin carboxylase is not completely rate-limiting, otherwise the 
D
V would have been unity since 
the isotope sensitive step is part of the second half-reaction. Thus, the isotope effects suggest that 
both half-reactions are partly rate-limiting. 
Initial Velocity Patterns 
The initial velocity pattern for an enzyme with a ping-pong kinetic mechanism is 
expected to show a set of parallel lines in a double reciprocal plot. In other words, when varying 
                                                 
1 The removal of a proton from the methyl group of acetyl-CoA is analogous to a keto-enol conversion. Keeffe and 
Kresge (1996) measured the deuterium isotope effect on the enolization of isobutyrophenone as 6.2. Therefore, the 
intrinsic isotope effect for substituting deuterium for hydrogen at the methyl group of acetyl-CoA is estimated to be 
about 6.2. 
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the concentration of the substrate for a particular half-reaction, the slope in a double reciprocal 
plot is not a function of the concentration of the substrate for the other half-reaction. When ATP 
was varied at different fixed levels of acetyl-CoA (Figure 2.3 A), the data fit best to Equation 3, 
which describes a set of parallel lines expected for a ping-pong kinetic mechanism. 
In contrast, when acetyl-CoA was varied at different fixed levels of ATP (Figure 2.3 B), a 
set of intersecting lines was observed. The data in Figure 2.3 B were fitted to both Equation 2 
and Equation 3. The data fit best to Equation 2, describing a sequential initial velocity pattern, 
based on the fact that the average least squares of the residuals were the lowest for Equation 2. 
The intersecting initial velocity pattern in Figure 2.3 B indicates that all substrates (in this case 
ATP and acetyl-CoA) must be on the enzyme for catalysis to occur. A change in slope with 
increasing ATP means that even at very low acetyl-CoA, ATP affects the reaction rate. This 
suggests communication between the biotin carboxylase and carboxyltransferase active sites. 
The two initial velocity patterns are seemingly contradictory in that when ATP is varied 
at fixed levels of acetyl-CoA a ping-pong mechanism is indicated while the intersecting pattern 
when acetyl-CoA is varied at fixed levels of ATP is characteristic of a sequential mechanism. 
These two contradictory observations can be reconciled by noting that an initial velocity pattern 
for a sequential mechanism can resemble the pattern for a ping-pong mechanism. If the Kia 
parameter in Equation 2 (which is the dissociation constant for A) was much less than the  
Michaelis constant for A (Ka) then Equation 2 would be approximately equal to Equation 3 and 
the initial velocity would appear as a set of parallel lines (Cook and Cleland, 2007). However, 
despite the appearance of a ping-pong kinetic mechanism the true mechanism is in fact 
sequential. 
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Figure 2.3 Initial velocity patterns of acetyl-CoA carboxylase. A) initial velocity pattern versus 
ATP concentration at different fixed levels of acetyl-CoA at 0.3 mM (), 0.6 mM () and 1.2 
mM (). B) initial velocity pattern versus acetyl-CoA concentration at different fixed levels of 
ATP at 2 µM (), 5 µM (), 10 µM () and 20 µM (). Both assays contained 2 µM BCCP, 
0.32 µM BC, and 0.24 µM CT in each reaction. The points represent the observed velocities, and 
the lines represent the best fit of the data to equation 3 (A) and equation 2 (B). 
 
It is important to point out that the kinetics observed here with the bacterial form of the 
enzyme are very similar to those observed with various forms of eukaryotic acetyl-CoA 
carboxylase. For instance, initial velocity patterns of acetyl-CoA carboxylase from chicken liver 
(Beaty and Lane, 1982), maize (Herbert et al., 1996), and the human mitochondrial isoform 
(Kaushik et al., 2009) all exhibit an intersecting initial velocity pattern when acetyl-CoA is 
varied at different fixed levels of ATP and when ATP is varied at different fixed levels of acetyl-
CoA. The authors of each of those studies concluded that the two different active sites in the 
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various eukaryotic acetyl-CoA carboxylases interact or communicate with each other and that the 
enzyme does not have a strict ping-pong kinetic mechanism. 
Inhibition Studies 
Given that acetyl-CoA carboxylase did not show an initial velocity pattern expected of a 
ping-pong enzyme, dead-end inhibition analyses were carried out to further probe the kinetic 
properties of the enzyme. Enzymes with ping-pong kinetic mechanisms would be expected to 
exhibit uncompetitive inhibition when the substrate for a half-reaction is varied with different 
fixed levels of an inhibitor that binds to the enzyme catalyzing the other half-reaction. Therefore, 
an inhibitor of biotin carboxylase was examined as a function of varying levels of acetyl-CoA, 
while an inhibitor of carboxyltransferase was examined as a function of varying levels of ATP. 
The biotin carboxylase inhibitor, 2-aminooxazole dibenzylamide, was developed by 
Pfizer as an antibiotic and was found to be competitive with respect to ATP (Mochalkin et al., 
2009). The carboxyltransferase inhibitor, andrimid, is a natural product antibiotic that exhibits 
competitive inhibition with respect to acetyl-CoA (Freiberg et al., 2004). The 2-aminooxazole 
dibenzylamide inhibitor of biotin carboxylase would be expected to exhibit uncompetitive 
inhibition with respect to acetyl-CoA if acetyl-CoA carboxylase is a strictly ping-pong 
mechanism. Likewise, the carboxyltransferase inhibitor, andrimid, would be expected to exhibit 
uncompetitive inhibition with respect to ATP. However, as shown in Figure 2.4 A and B, 2-
aminooxazole dibenzylamide is a noncompetitive inhibitor versus acetyl-CoA, while andrimid is 
a noncompetitive inhibitor versus ATP, respectively. The noncompetitive inhibition pattern 
indicates that inhibitor binding at the active site of either biotin carboxylase or 
carboxyltransferase is affecting binding and catalysis in the other enzyme, which again implies 
communication between the two proteins. 
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Figure 2.4 Dead-end inhibition of acetyl-CoA carboxylase. A) Inhibition by 2-aminooxazole 
dibenzylamide at 0 µM (), 0.5 µM (), and 1 µM () while varying acetyl-CoA and holding 
ATP constant at 10 µM. B) Inhibition by andrimid at 0 nM () and 15 nM () while varying 
ATP and holding acetyl-CoA constant at 200 µM. Both assays contained 2 µM BCCP, 0.32 µM 
BC, and 0.24 µM CT in each reaction. The points represent the observed velocities, and the lines 
represent the best fit of the data to equation 4. 
 
Multiple Inhibition 
Since inhibitor binding at one active site affected the activity of the other enzyme, 
multiple inhibition analysis was undertaken to determine whether inhibitor binding to the active 
sites of biotin carboxylase and carboxyltransferase was synergistic or antagonistic. Multiple 
inhibition analyses were carried out by measuring the initial velocities at increasing 
concentrations of one inhibitor while the second inhibitor was held constant. Initial velocities 
were measured again at higher levels of the second inhibitor and then plotted as 1/velocity versus 
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the concentration of the first inhibitor (sometimes referred to as a Yonetani-Theorell plot) 
(Yonetani, 1982). The substrate concentrations were held constant at subsaturating levels. For 
multiple inhibition analysis of acetyl-CoA carboxylase, one inhibitor was the biotin carboxylase 
inhibitor 2-aminooxazole dibenzylamide. For the carboxyltransferase inhibitor, the product 
malonyl-CoA was used instead of andrimid because malonyl-CoA is water soluble whereas 
andrimid is dissolved in DMSO. The levels of andrimid required for multiple inhibition studies 
would exceed the amount of DMSO that acetyl-CoA carboxylase can tolerate. 
When 2-aminooxazole dibenzylamide was varied at different fixed levels of malonyl-
CoA, an intersecting pattern was observed that indicates the two inhibitors can bind to the 
enzyme simultaneously (Figure 2.5). When the data were fitted to equation 5, an α value of .69 
was obtained. The α value is an indication of the interaction of the two inhibitors. Values of α > 
1 indicate that the binding of the two inhibitors interfere with one another, while an α value of 1 
indicates no interaction between the inhibitors and an α value < 1 indicates synergism in the 
binding of the inhibitors. Thus, the fact that two inhibitors, which bind to biotin carboxylase and 
carboxyltransferase, interact synergistically suggests an interaction between the active sites. 
In summary, the steady-state kinetic analysis of acetyl-CoA carboxylase taken as a whole 
indicates the enzyme has some characteristics of an enzyme with a sequential kinetic mechanism. 
For example, all the substrates must be on the enzyme for catalysis to occur. The fact that acetyl-
CoA carboxylase does not behave as a ping-pong enzyme and that the two-half reactions are 
interacting implies a physical association between the proteins. In order to measure directly if the 
proteins comprising the multifunctional acetyl-CoA carboxylase form a complex, pull-down or 
co-immunoprecipitation assays were employed. 
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Figure 2.5 Multiple inhibition of acetyl-CoA carboxylase. Inhibition varying 2-aminooxazole 
dibenzylamide at different fixed levels of malonyl-CoA at 0 µM (), 200 µM (), and 300 µM 
(). ATP, acetyl-CoA, BCCP, BC, and CT were held constant at 10 μM, 399 μM, 2 μM, 0.32 
μM, and 0.24 μM, respectively. The points represent the observed velocities, and the lines 
represent the best fit of the data to equation 5. 
 
Pull-down Assays 
The rationale behind the pull-down assays was simply to pull-down one of the 
components of acetyl-CoA carboxylase and see if the other two components are also pulled-
down. Biotin carboxylase or carboxyltransferase was targeted for pull-down/co-
immunoprecipitation by placing an octapeptide FLAG-tag on the N-terminus of the protein. This 
allows anti-FLAG binding resin (which is an antibody to the FLAG peptide) to be used to pull 
down any complexes that form. To target biotinylated BCCP, the protein streptavidin was used 
because it binds biotin very tightly (Kd = 10
-15
 M) (Green, 1963). 
Pull-down assays of BCCP with streptavidin in the presence of carboxyltransferase and 
biotin carboxylase showed that all three components do indeed form a complex and that when 
BCCP was removed, only slight non-specific binding by carboxyltransferase was observed 
(Figure 2.6, lanes 5 and 6). Likewise, when FLAG-CT was pulled-down in the presence of biotin 
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carboxylase and BCCP, all three proteins were detected, and when FLAG-CT was removed, 
neither biotin carboxylase nor BCCP was observed (Figure 2.6, lanes 7 and 8). Finally, both 
carboxyltransferase and BCCP were pulled-down when FLAG-BC was targeted and were not 
pulled-down when FLAG-BC was absent (Figure 2.6, lanes 9 and 10). Thus, irrespective of 
which component of acetyl-CoA carboxylase is targeted, the other two components are also 
pulled-down. These data strongly suggest these proteins can form a complex, at least in vitro, 
and are consistent with the steady-state kinetic analysis. 
 
Figure 2.6 Pull-down assays targeting the individual components of acetyl-CoA carboxylase. 
Lane 1, anti-FLAG resin showing the heavy and light chains of the anti-FLAG resin antibodies. 
Lanes 2-4, input lanes of His-BCCP, FLAG-CT and FLAG-BC, respectively. Lanes 5-6, pull-
down assay using streptavidin beads to target biotinylated BCCP in the presence of BC and CT 
and absence of BCCP, respectively. Lanes 7-8, pull-down assay using anti-FLAG resin to target 
FLAG-CT in the presence of BCCP and BC and absence of FLAG-CT, respectively. Lanes 9-10, 
pull-down assay using anti-FLAG resin to target FLAG-BC in the presence of BCCP and CT and 
absence of FLAG-BC, respectively. 
 
In order to determine if the substrates have an effect on complex formation, pull-down 
assays targeting FLAG-BC were carried out in the presence or absence of acetyl-CoA and the 
non-hydrolyzable analog of ATP, AMPPNP. As shown in Figure 2.7, neither acetyl-CoA nor 
AMPPNP had any effect on complex formation. The lane containing only AMPPNP has similar 
band intensities within the lane, and the reduction in band intensities in comparison to the other 
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lanes is due to a reduced amount of resin at the end of the experiment. In addition, the mRNA 
coding for the α-subunit of carboxyltransferase, which has been shown to bind to 
carboxyltransferase (Meades et al., 2010), also did not have any effect on complex formation 
(data not shown). 
 
Figure 2.7 The effect of acetyl-CoA and AMPPNP on the pull-down assays targeting the 
individual components of acetyl-CoA carboxylase. In all lanes, FLAG-BC was targeted with 
anti-FLAG resin to pull-down CT and BCCP. Lane 1, Pull-down assay in the presence of 3.22 
mM acetyl-CoA and 1.67 mM AMPPNP. Lane2, Pull-down assay in the absence of acetyl-CoA 
and AMPPNP. Lane 3, Pull-down assay in the absence of acetyl-CoA and the presence of 1.67 
mM AMPPNP. Lane 4, Pull-down assay in the presence of 3.22 mM acetyl-CoA and the absence 
of AMPPNP. 
 
While the pull-down assays showed the three components of acetyl-CoA carboxylase 
form a complex in vitro, the next question was could the multiprotein complex also form in vivo? 
Initially, the bacterial two-hybrid system described by Dove et al. (1997) was used to detect in 
vivo interactions. This approach proved to be problematic and inconclusive, most likely because 
the technique involved fusing proteins to the N-termini of biotin carboxylase and 
carboxyltransferase. Therefore, to examine complex formation in vivo, a minioperon containing 
the genes for the α- and β-subunits of carboxyltransferase was constructed in one plasmid, while 
another plasmid with a different origin of replication, contained a minioperon with the genes 
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coding for biotin carboxylase and an N-terminal His-tagged BCCP. Overexpression of the genes, 
cell lysis, and purification of the His-tagged BCCP by nickel-affinity chromatography revealed 
that all of the subunits of acetyl-CoA carboxylase co-purify as a single complex (Figure 2.8). 
The complex remained intact even after gel filtration chromatography, where the major peak of 
acetyl-CoA carboxylase activity eluted before the 640 kDa standard (Figure 2.9 A and B). A 
molecular weight > 640 kDa indicates that the multiprotein complex is not simply composed of a 
biotin carboxylase homodimer bound to two monomers of BCCP and a heterotetramer of 
carboxyltransferase which would have a molecular weight of 269 kDa. Instead, the data suggests 
acetyl-CoA carboxylase is a large macromolecular complex. The stoichiometry of the 
multiprotein complex is not known and will have to await the determination of the crystal 
structure of acetyl-CoA carboxylase which is underway. 
 
Figure 2.8 Pull-down assay of acetyl-CoA carboxylase produced in vivo. Lane 1, SDS-PAGE of 
ACC after purification on a nickel affinity column. Lane 2, molecular weight markers. Lane 3, 
SDS-PAGE of ACC after affinity purification on an anti-FLAG column. 
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Figure 2.9 Gel filtration of acetyl-CoA carboxylase produced in vivo and in vitro. A) The solid 
black and grey lines denote the mAU of the elution off the size exclusion column for in vivo and 
in vitro holo-ACC respectively, and “holo-ACC” marks the peak containing ACC from the in 
vivo run, which corresponds to Lane 2 in B. The arrows at the top of the figure represent which 
mL the molecular weight markers elute. B) Lane 1, molecular weight markers. Lane 2, in vivo 
ACC after purification on a nickel-affinity column followed by a size exclusion column. 
 
In order to determine if the in vivo complex formation is not simply due to using His-
tagged BCCP, the whole process was repeated using FLAG-CT as the targeted protein and anti-
FLAG resin in place of the nickel affinity resin. The same results were obtained in that all three 
components co-purified on the anti-FLAG affinity column (Figure 2.8). To determine if the 
acetyl-CoA carboxylase complex is only stable when formed in vivo, purified biotin carboxylase, 
BCCP, and carboxyltransferase were combined and subjected to gel filtration chromatography. 
Just like the acetyl-CoA carboxylase that was produced in vivo, a peak eluting before the 640 
kDa standard was observed (Figure 2.10). SDS-PAGE analysis of the major peak showed it 
contained the four separate proteins that comprise acetyl-CoA carboxylase (Figure 2.10). The 
bands corresponding to the α- and β-subunits of CT in Figure 2.10 are slightly different from the 
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in vivo assembled acetyl-CoA carboxylase. Since the stoichiometry of the multiprotein complex 
is unknown, excess BCCP and BC was mixed with CT to ensure complex formation. Excess 
BCCP-BC forms a complex with a quaternary structure larger than 640 kDa (unpublished 
observations) that is outside the resolution range of the size exclusion column that would allow 
separation from holo-ACC and accounts for the differing band intensities in Figure 2.10. 
 
Figure 2.10 SDS-PAGE of acetyl-CoA carboxylase produced in vitro. Purified BC, BCCP, and 
CT were combined in vitro and then subjected to size exclusion chromatography. Lane 1, BCCP. 
Lane 2, FLAG-CT. Lane 3, BC. Lane 4, in vitro ACC after combining lanes 1-3 and purification 
over a size exclusion column. Lane 5, molecular weight markers. 
 
Thus, all of the evidence taken together (enzyme kinetics along with the in vitro and in 
vivo pull-down assays) strongly argue that acetyl-CoA carboxylase forms a higher order protein 
structure and that formation of this mulitprotein complex is necessary for regulating the 
enzymatic activity whereby ATP is only hydrolyzed in the presence of acetyl-CoA. 
Discussion 
Protein-protein interactions play a multitude of roles in cellular and organismal functions 
such as signal transduction, blood coagulation, immunity, etc. The complexes involved in PPI 
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have been characterized as being either obligate or non-obligate (Nooren and Thornton, 2003; 
Ozbabacan et al., 2011). Obligate PPI are distinguished from non-obligate PPI in that the 
different protein components cannot exist independently and that the protein interactions are 
irreversible (Perkins et al., 2010). Acetyl-CoA carboxylase seems to fall into both categories 
because biotin carboxylase and carboxyltransferase can be isolated and retain their enzymatic 
function indicative of a non-obligate PPI. However, all the components together form a 
multimeric complex that appears to be stable, at least to the extent that it remains intact after size 
exclusion chromatography, consistent with an obligate PPI. The results in this study provide the 
first evidence that all the components of acetyl-CoA carboxylase form a complex, which is in 
direct contrast to previous reports that the multienzyme complex is labile and transient in nature 
(Cronan and Waldrop, 2002; Polyak et al., 2012). 
These seemingly contrasting observations can be reconciled by noting that while biotin 
carboxylase and carboxyltransferase do indeed retain their catalytic activity when isolated, that 
activity is only observed when free biotin is used as a substrate (Guchhait et al., 1974). When 
biotin covalently linked to BCCP is the substrate, biotin carboxylase or carboxyltransferase have 
little to no activity. It is only when acetyl-CoA and all three components, biotin carboxylase, 
BCCP, and carboxyltransferase, are present that the enzyme exhibits full enzymatic activity. 
Therefore, the PPI in acetyl-CoA carboxylase could be termed obligate because the individual 
components do not function independently and the interactions are irreversible. The question 
now is: why do isolated biotin carboxylase and carboxyltransferase have activity with free biotin 
but not with biotin covalently linked to BCCP? 
 The N-terminal domain of BCCP appears to be the structural feature that impedes 
enzymatic activity of isolated biotin carboxylase or carboxyltransferase when BCCP is the 
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substrate. This conclusion is based on the observation that the biotinylated, C-terminal domain of 
BCCP (referred to as BCCP87 because it contains 87 amino acids) was an excellent substrate for 
isolated biotin carboxylase and carboxyltransferase (Chapman-Smith et al., 1994). In fact, the 
catalytic efficiency of BCCP87 for isolated biotin carboxylase and carboxyltransferase was 
8000- and 2000-fold higher than for free biotin, respectively (Blanchard et al., 1999a). In other 
words, in the absence of the N-terminal domain, BCCP works quite well as a substrate for either 
biotin carboxylase or carboxyltransferase. Therefore, one possible role for the N-terminal 
domain of BCCP is to inhibit catalysis by biotin carboxylase, thereby preventing wasteful ATP 
hydrolysis in the absence of carboxyltransferase and/or acetyl-CoA. 
 The lack of reversibility in the reaction catalyzed by acetyl-CoA carboxylase actually 
supports the idea that acetyl-CoA carboxylase catalyzes the rate-determining step in fatty acid 
synthesis (Davis et al., 2000). Specifically, the fact that acetyl-CoA carboxylase will not catalyze 
the reverse reaction (i.e. the conversion of malonyl-CoA into acetyl-CoA) means the first step in 
fatty acid synthesis is not at equilibrium, which is exactly what is wanted in a reaction that is the 
rate-determining step in a metabolic pathway. The consequence of the irreversibility of acetyl-
CoA carboxylase is that all of the product of the reaction, malonyl-CoA, will be utilized by fatty 
acid synthase, and thus, the flux through fatty acid synthesis will be at least partly determined by 
the number of enzyme molecules. This concept fits perfectly with the model proposed by 
Meades et al. (2010) wherein the stationary phase of E. coli growth, carboxyltransferase acts as a 
“dimmer switch” by binding to the mRNA coding for the α- and β-subunits, which inhibits 
translation as well as enzymatic activity. In contrast, during log phase, acetyl-CoA levels 
increase dramatically and compete with mRNA for binding to carboxyltransferase. This allows 
for substrate turnover as well as translation of mRNA to synthesize more carboxyltransferase 
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molecules, resulting in an increase in flux through fatty acid synthesis. Thus, acetyl-CoA, which 
acts as a sensor of the metabolic state of E. coli, regulates acetyl-CoA carboxylase, first by 
upregulating the synthesis of the carboxyltransferase component and second, by stimulating 
enzymatic activity. These two levels of regulation mediated by acetyl-CoA minimize the 
unnecessary hydrolysis of ATP whenever acetyl-CoA levels are low, while at the same time 
allowing the flux of the fatty acid synthetic pathway to be controlled by the number of enzyme 
molecules. 
 Lastly, the work described here not only examines the basic mechanism and regulation of 
acetyl-CoA carboxylase but it also has potential medical ramifications. Both biotin carboxylase 
and carboxyltransferase have been validated as new targets for antibiotic development. 
Compounds that inhibit biotin carboxylase (Miller et al., 2009; Mochalkin et al., 2009) and 
carboxyltransferase (Freiberg et al., 2004) have been found to have antibacterial activity. These 
compounds inhibit biotin carboxylase and carboxyltransferase in the traditional manner, by 
binding in the active sites and preventing substrate binding. However, because acetyl-CoA 
carboxylase clearly functions as a multiprotein complex, this greatly expands the number of 
potential target sites beyond only the active sites to also include the sites of protein-protein 
interactions for the different components of acetyl-CoA carboxylase. Moreover, the multienzyme 
complex provides the opportunity to make a multiligand inhibitor that incorporates both biotin 
carboxylase and carboxyltransferase inhibitors. Not only would an acetyl-CoA carboxylase 
multiligand inhibitor be potentially more potent than either one of the individual ligands, but a 
multiligand antibacterial agent would also lessen the chance of pathogenic bacteria developing 
resistance (Corson et al., 2008; Le Calvez et al., 2009; Morphy and Rankovic, 2005; Silver, 
2007). 
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CHAPTER 3 
THE THREE-DIMENSIONAL STRUCTURE OF THE BIOTIN CARBOXYLASE-
BIOTIN CARBOXYL CARRIER PROTEIN COMPLEX OF E. COLI ACETYL-COA 
CARBOXYLASE
1
 
 
Introduction 
Biotin-dependent acetyl-coenzyme A carboxylase (ACC) catalyzes the regulated step in 
fatty acid synthesis in all domains of life. In E. coli, ACC is made up of three components: biotin 
carboxylase (BC), biotin carboxyl carrier protein (BCCP), and carboxyltransferase (CT) (Cronan 
and Waldrop, 2002). The first step in the enzymatic reaction, catalyzed by BC, is the ATP 
dependent carboxylation of the vitamin biotin (Scheme 3.1), which is covalently attached to a 
specific lysine residue (Lys122) of BCCP. The second half-reaction carried out by CT is the 
transfer of the carboxyl group from the 1′N of carboxybiotin to acetyl-coenzyme A (acetyl-CoA) 
to form malonyl-CoA (Scheme 3.1). 
 
Scheme 3.1 Acetyl-CoA carboxylase half-reactions. 
 
The genes encoding BC (Li & Cronan, 1992a) and CT (Li & Cronan, 1992b) have been 
cloned, overexpressed (Blanchard et al., 1999b; Blanchard and Waldrop, 1998), retain their 
enzymatic function in the absence of the other components, and utilize free biotin as a substrate 
instead of biotin linked to BCCP (Guchhait et al., 1974). The structure of E. coli BC has been 
                                                 
1
 Structure, March 14, 2013; 21(4), 650-657. The Three-Dimensional Structure of the Biotin Carboxylase-Biotin 
Carboxyl Carrier Protein Complex of E. coli Acetyl-CoA Carboxylase. Reprinted by permission of Structure and 
Elsevier. 
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determined in the absence of substrates (Thoden et al., 2000; Waldrop et al., 1994) and with 
ATP analogues AMPPNP and ADPCF2P (Mochalkin et al., 2008) and with biotin, bicarbonate, 
and Mg-ADP (Chou et al., 2009). The structure of CT has also been determined (Bilder et al., 
2006). In addition, the structure of the C-terminal domain of BCCP, which contains the 
biotinylated lysine, has been determined by X-ray crystallography (Athappilly and Hendrickson, 
1995) and nuclear magnetic resonance (NMR) (Yao et al., 1997). While the three-dimensional 
structures of the individual components have been of inestimable value, the fact remains that 
BCCP is the substrate for BC and CT, and therefore, what is lacking is a structure of either the 
biotin carboxyl carrier protein-biotin carboxylase (BCCP-BC) complex or the biotin carboxyl 
carrier protein-carboxyltransferase complex. 
It was found that a stable BCCP-BC complex formed when purifying BCCP from an E. 
coli strain that coexpressed both proteins (Nenortas and Beckett, 1996), while Choi-Rhee and 
Cronan (2003) suggested that the stoichiometry of the protein complex was one BC homodimer 
bound to four BCCP molecules. Thus, since BC and BCCP form a complex, we undertook the 
determination of the crystal structure of that protein-protein interaction. Here we report the three-
dimensional structure of the E. coli BCCP-BC complex to 2.49 Å resolution. The structure 
indicates a stoichiometry different from that previously reported (Choi-Rhee and Cronan, 2003) 
and reveals a quaternary structure for BC that has heretofore never been observed. 
Experimental Procedures 
Reagents 
Amicon Ultra Centrifugal Filters MW cutoff 10,000 and Millex-HP 0.45 μM filter units 
were from Millipore. Bradford protein assay reagent and gel filtration standards were from Bio-
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Rad. Expression vectors, Perfect Protein Markers, Nova Blue competent cells, and BL21(DE3) 
competent cells were obtained from Novagen. Kanamycin and IPTG were from Gold 
Biotechnology. Restriction endonucleases, T4 DNA ligase, and dNTPs were purchased from 
New England Biolabs. Pfu Ultra II fusion was from Agilent. All primers were synthesized by 
Eurofins MWG Operon. Highload 16/60 Superdex 200 prepgrade gel filtration column was from 
Amersham Biosciences, TSK gel G3000SWXL column was from Tosoh Bioscience, and HisTrap 
HP Ni Sepharose columns were from GE Healthcare. Crystallization reagents, 24-well sitting 
drop trays, 0.1-0.2 mm mounted cryoloops, and CrystalCap Magnetic caps were purchased from 
Hampton Research. All other reagents were from Sigma/Aldrich. 
Expression Vector Construction 
In order to generate a BCCP-BC complex, a minioperon containing the accB and accC 
genes was constructed. The primers BCCP5 and BCCP3 (shown below) were used to amplify the 
E. coli BCCP gene (accB) using pYML11 as a template because it contains the gene for E. coli 
BCCP in pGEM7 between the EcoRI and BamHI cut sites. The primers introduced an NdeI site 
on the 5′ end of the gene and on the 3′ end of the gene a ribosomal binding site of the sequence 
5′-AAGGAG-3′ followed by a BamHI cut site. The PCR product was digested with NdeI and 
BamHI and ligated into pET28b(+) cut with the same enzymes to create pAEP3. The accC gene 
was amplified from pGLW1 (Blanchard et al., 1999b) using the primers BC5 and BC3 (shown 
below) to introduce a 5′ BamHI site and a 3′ XhoI site. The PCR product was digested with 
BamHI and XhoI and ligated into pAEP3 cut with the same enzymes to create pAEP7. The final 
product was a plasmid containing an accBC minioperon with a 13 bp intercistronic region that 
expressed an N-terminal HIS-tagged BCCP and BC. 
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Primer     DNA Sequence 
BCCP5 (5′ -CTTCTTCATATGGATATTCGTAAGATTAAAAAA- 3′) 
BCCP3 (5′ -CTTCTTGGATCCACCTCCTTACTCGATGACGACCAGCGGCTC- 3′) 
BC5  (5′ -CTTCTTGGATCCGATGCTGGATAAAATTGTTATTGCC- 3′) 
BC3  (5′ -CTTCTTCTCGAGTTATTTTTCCTGAAGAACGAG- 3′) 
Protein Expression in E. coli 
The BCCP-BC complex or BC was expressed by transforming E. coli strain BL21(DE3) 
with pAEP7 or pGLW2 (Blanchard et al., 1999b), respectively. A freshly transformed colony 
was then used to inoculate either 0.5 L of LB medium in a 2 L flask or 1 L of LB medium in a 
2.8 L Fernbach flask. Each flask contained 30 µg/mL kanamycin. The cultures were incubated at 
37 °C with shaking until reaching mid-log phase or a 0.6 O.D. at which point they were allowed 
to cool for 15 min (at 25 °C) then induced with 250 µM IPTG. After a 2.5-3.5 h induction with 
shaking at 25 °C, the cells were harvested by centrifugation and frozen at -20 °C. 
Protein Complex Purification 
Cell pellets were suspended in equilibration/wash buffer (20 mM NaH2PO4, 500 mM 
NaCl, 15 mM imidazole, pH 7.8), sonicated, and passed through a French press to lyse the cells. 
Nucleic acids were removed by the addition of DNAse. The cell lysate was centrifuged at 34540 
g for 1 h at 4 °C. The supernatant was filtered with a 0.45 μM filter from Millipore and loaded 
onto a nickel affinity column pre-equilibrated with equilibration/wash buffer and then washed 
with ten column volumes of the same buffer. The protein complex was eluted using a segmented 
gradient starting with eight column volumes of 0-10% elution buffer (20 mM NaH2PO4, 500 mM 
NaCl, 250 mM imidazole, pH 7.8), followed by 12 column volumes of 10-100% elution buffer 
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and finally eight column volumes of 100% elution buffer. Protein complex from the nickel 
affinity column was then concentrated via Amicon Centrifugal Filters at 3889 g and loaded onto 
a Hi-Load 16/60 Superdex 200 column pre-equilibrated with 10 mM Hepes, 500 mM KCl, pH 
7.8 for purification on a TSK gel G3000SWXL column pre-equilibrated with 50 mM Na2HPO4, 
50 mM NaH2PO4, 150 mM NaCl, 10 mM Hepes, pH 6.8 for analysis. Fractions containing pure 
BCCP-BC complex were concentrated and stored at -80 °C. 
Crystallization 
Crystals were obtained by sitting drop vapor diffusion at room temperature using a 10 
mg/mL solution of the BCCP-BC complex. The crystallization condition contained a reservoir 
solution of 0.2 M ammonium sulfate, 0.1 M BIS-TRIS (pH 6.5), and 25% w/v PEG 3350. The 
sitting drop contained a well to protein ratio of 1.75:2 µL. Crystals appeared after three months 
and were cryoprotected with a 30% v/v ethylene glycol/reservoir solution and then mixing that 
solution with crystal mother liquor in a 1:1 ratio. The crystal was submerged in the 
cryoprotectant and then immediately flash-cooled in liquid nitrogen. 
X-ray Data Collection, Structure Determination, and Refinement 
X-ray diffraction data were collected to 2.49 Å at the Advanced Photon Source beamline 
NE-CAT 24-ID-E equipped with the ADSC Q315r detector. The data was processed and scaled 
using XDS (Kabsch, 2010). The crystal belonged to the C2 space group and had unit cell 
parameters a = 233.0 Å, b = 96.4 Å, c = 120.6 Å and β = 120.2°. The asymmetric unit contained 
two BC homodimers and each monomer of BC was in complex with one BCCP molecule. The 
phase information was obtained by molecular replacement using Phaser (Adams et al., 2010) and 
a BCCP-BC heterodimer search model that was acquired from the solution of a 3.7 Å data set of 
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a different crystal form (Table 3.1). The molecular replacement solution was further refined 
using several cycles of phenix.refine (Adams et al., 2010) and manual rebuilding in COOT 
(Emsley and Cowtan, 2004). All water molecules and ions added were manually verified after 
the final refinement. The final model consists of residues 1-163 and 167-446 for BC molecule A, 
77-156 for BCCP molecule B, 1-161, 170-182, and 196-446 for BC molecule C, 79-156 for 
BCCP molecule D, 1-159,170-183, and 197-446 for BC molecule E, 1-160, 169-184, and 196-
446 for BC molecule F, 80-156 for BCCP molecule G, 80-156 for BCCP molecule I, and 455 
water molecules. Twelve sulfate ions and one ethylene glycol molecule were included in the 
final model based on the shape of the difference electron density, composition of the 
crystallization and cryoprotectant solutions, and the refined B-factors. Data collection statistics 
are shown in Table 3.1. 
Crystal Structure Determination (P21 Crystal Form) 
The molecular replacement procedure was applied to locate a solution. First, a monomer 
of biotin carboxylase (PDB accession code 1DV1) was used as a search model. Four monomers 
were located by using the program MOLREP (Bailey, 1994). Their positions were fixed and a 
monomer of the biotin carboxyl carrier protein (PDB accession code 1BDO) was used in the 
additional molecular replacement search with MOLREP. Four BCCP monomers were located in 
the asymmetric unit producing a hetero-octamer for the BCCP-BC complex. The positioned MR 
model was refined in REFMAC (Bailey, 1994) using local non-crystallographic restrains and 
“jelly” body refinement which resulted in R = 20.70 and Rfree = 31.15%. No model building or 
additional refinement has been performed because of low resolution of the data set (3.74 Å) and 
our further structure determination attempts were directed into the improvement of the resolution 
limits of the crystals. 
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Table 3.1 Data Collection and Refinement Statistics for BCCP-BC Structures 
Data Collection   
Space group  C2  P21 
Cell dimensions   
a, b, c (Å)  233.0, 96.4, 120.6  100.6, 200.7, 121.3 
β (°)  120.2 104.1 
Resolution (Å)  2.49 3.74 
Rsym
ab
 6.2 (33.1) 19.2 (65.9) 
I / σI  11.2 (2.4) 7.2 (2.6) 
Completeness (%)   98.5 (93.7) 98.3 (92.4) 
Redundancy  2.5 (2.5) 4.3 (4.0) 
Refinement   
Resolution (Å)  104.3-2.49  
Number of reflections  79,181  
Rwork / Rfree
c
 19.50/22.91  
Number of atoms  16,162  
Protein  15,643  
Ligand/ion  64  
Water 455  
B-factors   
Protein 39  
Ligand/ion 34  
Water 26  
RMSD   
Bond lengths (Å) 0.003  
Bond angles (°) 0.72  
a
Values in parentheses are for the highest-resolution shell. 
b
Rsym = (Σ|Ii - <Ii> |/Σ|Ii|)*100, where Ii is the intensity of the i
th
 observation and <Ii> is 
the mean intensity of the reflection. 
cR = (Σ||fo| - |fc||/Σ|fo|)*100, where Fo and Fc are the observed and calculated structure 
factor amplitudes, respectively. Rfree is calculated using 5% of reflections omitted from 
the refinement. 
 
Programs 
The programs used for calculating RMSDs and accessible surface areas were PDBefold 
(Krissinel and Henrick, 2004) and PISA (Krissinel and Henrick, 2007), respectively. 
Accession Number 
The atomic coordinates and structure factors for the BCCP-BC crystal structure have 
been deposited in the Protein Data Bank under accession number 4HR7. 
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Results and Discussion 
Co-purification of BCCP and BC 
The genes encoding BCCP (accB) and BC (accC) are located in an operon in the E. coli 
chromosome and are co-transcribed (James and Cronan, 2004). To mimic the in vivo 
arrangement, accB and accC were coexpressed using a minioperon where a histidine-tag was put 
on the N-terminus of BCCP. After purification by nickel affinity and size exclusion 
chromatography, the major peak contained the BCCP-BC complex, which was used for 
crystallization (Figure 3.1 A). Gel electrophoresis showed a band at 50 kDa corresponding to the 
BC monomer and a band at ~22 kDa that is indicative of full length BCCP (Figure 3.1 B). The 
BCCP runs slightly higher than its 16.7 kDa molecular weight; this is thought to be caused by a 
pro/ala rich linker in the middle of the protein (Li and Cronan, 1992). Most importantly, the fact 
that the BCCP-BC complex remains intact after both nickel affinity and size exclusion 
chromatography suggests the BCCP-BC interaction is indeed stable. 
Quaternary Structure 
The overall structure of the BCCP-BC complex has D2 symmetry and is shown in Figure 
3.2 A-C. One of the most striking features of the BCCP-BC complex is that two BC homodimers 
(which have C2 symmetry) come together to form a tetramer. If the BC tetramer is viewed by 
looking at one homodimer on top of the other it becomes readily apparent that the homodimers 
are rotated approximately 90° with respect to one another (Figure 3.2 C). Tetrameric BC, in the 
BCCP-BC complex is in stark contrast to the structures reported to date of BC, which have 
shown the enzyme to be a homodimer with C2 symmetry (Chou et al., 2009; Mochalkin et al., 
2008; Thoden et al., 2000; Waldrop et al., 1994). Moreover, there are no packing interfaces in  
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Figure 3.1 Purification and SDS-PAGE analysis of the BCCP-BC complex. A) Size exclusion 
chromatography profile showing mAU vs. elution volume of proteins chromatographed on a 
Tosoh TSK gel G3000SWXL column. Arrows at the top of the graph indicate peak elution 
volumes of molecular weight standards and blue dextran. BCCP-BC complex and BC profiles 
are shown as black and grey lines, respectively, and are depicted by name above their elution 
peak. B) SDS-PAGE gel showing molecular weight standards in lane 1 and lane 2 exhibiting full 
length BCCP (22kDa) and BC (50kDa) from the BCCP-BC gel filtration peak in A. This figure 
represents the protein used to crystalize the structure shown in Figure 3.2. 
 
the crystals of BC alone that display the same dimer-dimer interaction as the BCCP-BC 
complex. 
 The tetramer of BC is bound to four BCCP molecules where each BCCP molecule forms 
two interfaces. One interface is with a BC monomer located in the upper homodimer while the 
other is with a BC monomer in the lower homodimer of the tetramer (Figure 3.2 A and B). Thus, 
the four BCCP molecules essentially act as molecular clips to hold two BC homodimers together 
to form a tetramer. It is important to note that the stoichiometry of two BC dimers plus four 
BCCP molecules observed here does not agree with the stoichiometry previously reported of one  
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Figure 3.2 Quaternary structure of the BCCP-BC complex. A, B and C) Surface rendering of the 
BCCP-BC complex showing the BC homodimer in purple (top) and yellow (bottom) with 
individual BCCPs shown in blue, green, orange, and red. B is A rotated 90 ° to the left and C is 
A rotated 90 ° around the x-axis in a clockwise motion. The local symmetry axes of the BCCP-
BC complex are also indicated in A and C. D) Cartoon representation of a monomer of BC with 
the two interfacing BCCP molecules in orange and green, respectively. The N-terminal domain, 
B-domain, and the C-terminal domain of the BC monomer are labeled and colored in light blue, 
dark blue, and yellow, respectively. Lys122 is represented as black sticks in each BCCP 
molecule with oxygen and nitrogen atoms in red and blue, respectively. The thumb of each 
BCCP molecule is designated by dashed circles. 
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BC dimer and four BCCP molecules (Choi-Rhee and Cronan, 2003). Moreover, these 
investigators also concluded that the N-terminal domain of BCCP was required for the 
interaction of BCCP with BC (Choi-Rhee and Cronan, 2003). As can be seen in Figure 3.2 D it is 
the C-terminal region of BCCP that interacts with BC which is consistent with kinetic studies 
showing the C-terminal domain is a substrate for BC (Blanchard et al., 1999a). Electron density 
for the N-terminal region of BCCP was not observed presumably due to inherent flexibility in 
this region of the molecule. Control experiments in which crystals of the BCCP-BC complex 
were run on SDS-PAGE show that the N-terminal domain is, in fact, attached to the C-terminal 
domain. The high degree of flexibility of the N-terminal domain of BCCP was also observed (by 
the lack of NOEs) in the N-terminal region of the 1.3S subunit of the homologous biotin-
dependent enzyme transcarboxylase (Reddy et al., 1998). The N-terminal region of the 1.3S 
subunit is involved in contacts with the other subunits of transcarboxylase (Carey et al., 2004) 
and by inference the N-terminal domain of E. coli BCCP may also interact with the CT subunit 
of acetyl-CoA carboxylase. Moreover, the fact that the N-terminal domain of BCCP is not 
involved in binding to BC is consistent with the observations that this domain down regulates 
transcription of the accBC operon (James and Cronan, 2004). Thus, if BCCP and BC form a 
complex in vivo, then it is reasonable to assume that the N-terminal domain of BCCP must 
remain unhindered so it could bind DNA and act as a transcriptional repressor. 
The quaternary structure shown here of two BC homodimers and four BCCP molecules 
has a molecular weight of ~260 kDa. Yet, the size exclusion chromatography data show a 
molecular weight greater than 640 kDa for the BCCP-BC complex (Figure 3.1 A). Thus, the 
structure observed here is likely a monomer of a much larger complex. For instance, if the ~260 
kDa BCCP-BC complex shown here were a trimer it would have a molecular weight of ~800 
95 
 
kDa, which would be consistent with the three-fold axis of symmetry observed in two other 
biotin-dependent enzymes, propionyl-CoA carboxylase (Huang et al., 2010) and methylcrotonyl-
CoA carboxylase (Huang et al., 2012). 
Several lines of evidence indicate that the BCCP-BC complex described here is 
physiologically relevant. First, the minioperon of BCCP-BC used in this study mirrors the 
operon and cotranscription of these two proteins that normally occurs in the cell. The reason that 
only a homodimer of biotin carboxylase has been crystallized before is because the gene for the 
enzyme was overexpressed in the absence of BCCP which does not mimic the in vivo situation. 
Moreover, the homodimer of biotin carboxylase observed in previous crystal structures is part of 
the homotetramer observed here where the interaction of two homodimers forms a tetramer that 
is mediated by BCCP. Second, the formation of a BCCP-BC complex is also consistent with the 
observations that BCCP by itself forms aggregates (Choi-Rhee and Cronan, 2003; Nenortas and 
Beckett, 1996). Thus, formation of a complex between BCCP and BC is more likely to be the 
case in vivo rather than BC existing as a homodimer and BCCP as an aggregate. Third, the 
BCCP-BC complex presented here is unlikely to be a consequence of the crystallization 
conditions because the same structure was observed under different crystallization conditions 
and in a different crystal form albeit at a lower resolution (3.7 Å) (Table 3.1). 
BCCP Structure 
 The overall structure of the C-terminal domain of BCCP bound to BC is virtually 
identical to the crystal (Athappilly and Hendrickson, 1995) and NMR (Yao et al., 1997) 
structures of the C-terminal domain of BCCP. The root-mean-square deviations (RMSD) 
between the equivalent Cα atoms of BCCP molecule B in the BCCP-BC complex and the crystal 
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and NMR structures were 0.64 Å and 1.28 Å, respectively. When the E. coli BCCP molecules 
observed in the complex were superimposed to the Cα atoms of the BCCP domain from human 
ACC2 (Lee et al., 2008) and the 1.3S subunit of transcarboxylase from Propionibacterium 
shermanii (Reddy et al., 1998), the RMSD was 1.7 Å and 1.5 Å, respectively. Although, the 
RMSDs were calculated between the Cα atoms of matching residues, the major difference 
between these molecules is the lack of a “thumb” in the non-E. coli proteins (Figure 3.3). This 
“motif” is not involved in interacting with BC and extends out away from the main body of the 
BCCP-BC complex (Figure 3.2 D). Mutations in this region of E. coli BCCP were found to 
impair the growth of E. coli suggesting that it is important for the function of the protein; 
however, the chemical mechanism for this phenotype is not understood (Cronan, 2001). 
 
Figure 3.3 Superposition of BCCP. Superposition of E. coli BCCP from the BCCP-BC complex 
(purple) with the BCCP domain from human acetyl-CoA carboxylase (yellow) and the 1.3S 
subunit of transcarboxylase (green). The β-hairpin turns can be seen pointing to the left and the 
thumb of the E. coli BCCP is “thumbs up” toward the top of the figure. 
 
 The hairpin turn in BCCP that contains the lysine residue that is biotinylated also 
protrudes away from the main body of the BCCP-BC complex (Figure 3.2 D). The Cα of Lys122 
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is about ~40 Å from Arg338, which is an active site residue that is important for catalysis 
(Sloane and Waldrop, 2004). The Cα of Lys122 was used as a reference because no electron 
density for the side chain of this residue was observed. This distance is consistent with the 
structures of related biotin-dependent holoenzymes, propionyl-CoA carboxylase, pyruvate 
carboxylase and methylcrotonyl-CoA carboxylase, which have distances between the BC and CT 
active sites of 55, 75 and 80 Å, respectively (Huang et al., 2012; Huang et al., 2010; Xiang and 
Tong, 2008). Considerable movement of the BCCP domain has been proposed for catalysis by 
other biotin-dependent carboxylases (Huang et al., 2012; St Maurice et al., 2007; Xiang and 
Tong, 2008) and BCCP has been observed in different positions in the cryo-electron microscopy 
studies on propionyl-CoA carboxylase (Huang et al., 2010). Thus, it is not surprising that the E. 
coli BCCP is ~40 Å away from the BC active site and may possibly be equidistant from where 
the BC and CT active sites would be in a full structure (~80 Å). 
The large distance between biotinylated BCCP and the active site is also in accord with 
reports that the BCCP-BC complex exhibits little to no catalytic activity in the absence of CT 
(Alves et al., 2011; Soriano et al., 2006). Measurements of the enzymatic activity of the BCCP-
BC complex used in this study confirm the previous studies in that the activity of the BCCP-BC 
complex was 0.005 µmol/min/mg, while the activity in the presence of CT and acetyl-CoA 
increased markedly (0.530 µmol/min/mg) suggesting that BCCP in the complex was at least 
partially biotinylated. Thus, the BCCP-BC complex is catalytically competent but only when 
complexed with CT and acetyl-CoA. The fact that the BCCP-BC complex is only active in the 
presence of CT and acetyl-CoA is important for the regulation of enzyme activity because it 
means that ATP will only be hydrolyzed when acetyl-CoA is present. This is a classic example 
of substrate synergism in which the wasteful hydrolysis of ATP is prevented unless all the 
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substrates are present. The structure reported here provides a structural context for understanding 
why the BCCP-BC complex is inactive in that the loop containing Lys122 to which biotin is 
attached is far away from the active site of biotin carboxylase. How the activity of the BCCP-BC 
complex is increased in the presence of CT and acetyl-CoA will have to await the structure of 
holo-acetyl-CoA carboxylase. 
The fact that the hairpin loop is exposed to the solvent is also consistent with the 
observation that it is not biotinylated. Lys122 in BCCP is biotinylated by biotin protein ligase 
and, therefore, must be readily accessible in vivo. A superposition of the structure of Pyrococcus 
horikoshii biotin protein ligase complexed with BCCP (Bagautdinov et al., 2008) with the E. coli 
BCCP in the BCCP-BC complex shows the biotin protein ligase rests alongside BC with very 
little steric overlap (Figure 3.4). Thus, the structure of the BCCP-BC complex observed here is 
exactly what would be expected if the BCCP is not biotinylated. 
BC Structure 
 The structure of the BC component in the BCCP-BC complex is virtually identical to 
previously determined structures of the BC homodimer (Chou et al., 2009; Mochalkin et al., 
2008; Thoden et al., 2000; Waldrop et al., 1994). A superposition of the BC homodimer with 
one of the BC homodimers in the complex yielded a RMSD of 0.76 Å. BC is a member of the 
ATP-grasp superfamily of enzymes that all have a similar tertiary structure composed of three 
domains: N-terminal, C-terminal, and B-domain (Figure 3.2 D) (Galperin and Koonin, 1997). 
The N- and C-terminal domains form the main body of the BC monomer while the B-domain 
either extends away from the other domains in the absence of ATP or rotates 45° to cover the 
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active site in the presence of ATP (Thoden et al., 2000). In the BCCP-BC complex the B-domain 
is splayed open and therefore consistent with no substrates being bound. 
Although the BCCP-BC complex described here did not contain any substrates, there was 
electron density in each BC active site that could be represented as an anion the size of 
phosphate or sulfate. Phosphate anions have been observed in structures of homodimeric BC 
(Thoden et al., 2000; Waldrop et al., 1994); however, sulfate ions were modeled in the BCCP-
BC complex due to the high concentration of ammonium sulfate in the crystallization solution. 
 
Figure 3.4 Superposition of BCCP from the E. coli BCCP-BC complex and the BCCP-biotin 
protein ligase complex from P. horikoshii. Biotin carboxyl carrier protein-biotin carboxylase 
complex is shown in purple and the biotin carboxyl carrier protein-biotin protein ligase complex 
is shown in gold. The superposition of the unbiotinylated BCCPs depicts a conformational state 
of the BCCP-BC complex by which biotin protein ligase can biotinylate the BCCP-BC complex. 
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BCCP-BC Interfaces 
BCCP binds to BC via two different interfaces. In the first interface, BCCP binds to the 
N-terminal domain of BC. The amino acids involved are located at the C-terminus of strands β2 
and β3 in BC and a loop connecting two β strands in BCCP (Figure 3.5 A and B). One 
interaction involves the carbonyl oxygen of Cys50 from BC forming a hydrogen bond with the 
peptidic NH of Phe148 of BCCP, while in a second interaction the peptidic NH of Cys50 
hydrogen bonds to the carboxylate group of Glu147 from BCCP. In addition, the side chains of 
His32 and Thr48 from BC interact with the carboxylate group of Glu147 from BCCP via a water 
molecule. Consistent with Glu147 being involved in binding to BC is that mutation of Glu147 to 
Lys (Chapman-Smith et al., 1999) in the domain comprising the C-terminal 87 residues of 
BCCP, which does exhibit activity with BC, (Blanchard et al., 1999a) resulted in over a 100-fold 
increase in the Km (unpublished data). 
In the second interface the opposite end of the BCCP molecule interacts with residues in 
the N- and C-terminal domains of BC located in the opposite half of the BC tetramer (Figure 3.5 
A and C). Residues involved in this interface stem from the β1 strand of BCCP and the BC 
residues 56 and 57 located in a loop along with amino acids in the turn between two β strands. 
Specifically, the carboxylate of Asp149 of BCCP forms a hydrogen bond with the hydroxyl 
group of Tyr380 from BC (Figure 3.5 C). The rest of the interactions at this interface are 
mediated through a putative sulfate ion and a water molecule (Figure 3.5 C). The presumed 
sulfate ion likely replaced a phosphate group, which was the case observed in the active site of 
BC described above. The residues in BC involved in this interaction are the side chain of Ser56 
and the peptidic NH group of Tyr381, while in BCCP the interacting groups were the side chain 
of Arg84 and the peptidic NH group of Ile82. It is important to note, the BCCP-BC complex was  
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Figure 3.5 The BCCP-BC complex interfaces. Oxygen, nitrogen, sulfur atoms, and water are 
depicted in red, blue, gold, and red spheres, respectively. Residues are indicated by their single 
letter abbreviation followed by their residue number in E. coli. Dashed lines depict hydrogen 
bonds and fall within 2.41-3.25 Å. The color scheme remains constant throughout the figure. A) 
BC homodimers are shown in purple (top) and yellow (bottom) of the complex. The N-terminal 
domain, B-domain and C-terminal domain of one monomer of the yellow homodimer are labeled 
and colored light blue, dark blue, and yellow, respectively. One of the BCCP’s binding these two 
homodimers together is shown in orange with the β-hairpin turn pointing to the purple 
homodimer. B, C, and D correspond to the area that is enlarged in B, C, and D, respectively. B 
and C) A magnified view of the two BCCP-BC interfaces. D) A magnified view of the BC-BC 
interface. 
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stable to gel filtration chromatography in a buffer not containing sulfate and with a molecular 
weight consistent with a multimeric quaternary structure (Figure 3.1 A). 
The interactions observed in the E. coli BCCP-BC complex are similar to those observed 
for other biotin-dependent carboxylases in which structural information about the interaction of 
BCCP with either BC or CT is available (Fan et al., 2012; Huang et al., 2012; Huang et al., 
2010; Lietzan et al., 2011; St Maurice et al., 2007; Xiang and Tong, 2008). The interfaces 
between BCCP and BC or CT in other biotin-dependent carboxylases were small and composed 
mostly of hydrogen and ionic bonds. Moreover, the residues involved in the protein-protein 
interactions were not conserved. The explanation given for the relatively weak BCCP-BC 
interface interactions was that BCCP has to undergo a large translocation between the BC and 
CT active sites. If the interface interactions were strong, indicative of hydrophobic interactions, 
this would create a thermodynamic well preventing or slowing the ability of BCCP to translocate 
to the CT binding site. In fact, proteins that associate in a transient or non-obligatory manner 
show a general trend of interaction through hydrogen and ionic bonds instead of hydrophobic 
contacts (Nooren and Thornton, 2003; Ozbabacan et al., 2011). 
The similarities of the BCCP-BC interfaces between the E. coli proteins and other biotin-
dependent carboxylases are striking. The individual interfaces in the E. coli BCCP-BC complex 
are small, with buried surface areas of 240 Å
2
 for the interface with the putative sulfate ion and 
480 Å
2
 for the other. However, these two small interfaces are repeated four times in the complex 
giving a total buried surface area of 2880 Å
2
. Both interfaces are composed of hydrogen bonds 
and ionic interactions with no hydrophobic contacts. Moreover, the interface residues are not 
strictly conserved across a spectrum of Gram positive and Gram negative bacteria with the only 
exceptions being Cys50 and Tyr381 in BC and Glu147 in BCCP (Figure 3.6). 
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While the interfaces in the E. coli BCCP-BC complex are apparently strong enough to 
keep the complex intact on a gel filtration column, the small buried surface area for an individual 
BCCP molecule and the lack of hydrophobic interactions likely provide the appropriate amount 
of flexibility for movement of BCCP between the BC and CT active sites. Exactly how BCCP 
moves between the BC and CT active sites is not known. It might involve translocation of the 
entire BCCP as proposed in pyruvate carboxylase (St Maurice et al., 2007; Xiang and Tong, 
2008), propionyl-CoA carboxylase (Huang et al., 2010), and methylcrotonyl-CoA carboxylase 
(Huang et al., 2012) which is consistent with the lack of hydrophobic residues because any 
partial dissociation of BCCP would not expose any hydrophobic residues to solvent. 
 
Figure 3.6 Interface residues in E. coli BC and BCCP compared to homologous residues in other 
species. The number above the column denotes the residue number in E. coli BC or BCCP. 
Letters in red indicate a strictly conserved residue with respect to that found in E. coli BC or 
BCCP. The organism names are highlighted in pink and purple representing a negative or 
positive Gram reaction, respectively. This figure relates residues shown in Figure 3.5 to 
homologous residues in pathogenic bacteria. 
 
BC-BC Interface 
The BCCP-BC complex is also stabilized by a BC-BC interface. The buried surface area 
for the interface is small, 350 Å
2
, suggesting a weak interaction; however, there are two identical 
BC-BC interfaces, which effectively doubles the interaction energy (Figure 3.5 A and D). In fact, 
if the total buried surface area for the two BC-BC interfaces (700 Å
2
) is combined with the total 
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buried surface area for the BCCP-BC interfaces the total buried surface area for the complex is 
3580 Å
2
 which is consistent with the BCCP-BC complex being a permanent or obligate protein-
protein interaction (Ozbabacan et al., 2011). While the dissociation constant between BC and 
BCCP has not been determined this level of total buried surface area suggests it would be <10
-6
 
M (Ozbabacan et al., 2011). 
The interacting residues of the BC monomer are located in the C-domain in β-strands 15 
and 17 with the exception of Asp38, which is in the N-terminal domain of BC. The residues that 
form the interface are duplicated such that there is two-fold symmetrical relationship for the 
interactions at each interface (Figure 3.5 D). The two most prominent interactions are between 
the carbonyl oxygen of the strictly conserved Gly374 (Figure 3.6) and the side chain of Lys353 
and a hydrogen bond between the side chains of Thr376 and Asp38, which are shown in Figure 
3.5 D. 
Comparison to BCCP-BC Structures from Other Biotin-Dependent Enzymes 
While the structure presented here is the leading model of the BCCP-BC complex for 
acetyl-CoA carboxylase, the structure of BCCP and BC has been determined for related biotin-
dependent carboxylases such as pyruvate carboxylase (Lietzan et al., 2011; St Maurice et al., 
2007; Yu et al., 2009), propionyl-CoA carboxylase (Huang et al., 2010), methylcrotonyl-CoA 
carboxylase (Huang et al., 2012), and urea carboxylase (Fan et al., 2012). What distinguishes 
these enzymes from bacterial acetyl-CoA carboxylase is that the BC, BCCP and CT 
functionalities are either all part of a single polypeptide chain or the BCCP and BC domains are 
located on the same polypeptide. 
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The only holoenzyme structure that shows an interaction between the BC and BCCP 
domains is the structure of pyruvate carboxylase from Rhizobium etli (Lietzan et al., 2011; St 
Maurice et al., 2007). The interaction in the C-domain between BC and BCCP in R. etli pyruvate 
carboxylase is not the same C-domain interaction observed in the E. coli BCCP-BC complex 
(Figure 3.7 A). The reason for this difference becomes obvious in Figure 3.7 B which shows that 
in pyruvate carboxylase from R. etli there is a loop comprising residues Val52-Gly63 that 
protrudes from the main body of the protein at exactly the spot that the bacterial BCCP would 
bind to BC. Thus, the E. coli BCCP-BC complex described above does not have any similarities 
to BCCP-BC interactions observed in other biotin-dependent carboxylases. The apparent 
uniqueness of the bacterial BCCP-BC interaction is likely to be a consequence of not being  
 
Figure 3.7 Biotin carboxylase from E. coli superimposed onto the biotin carboxylase domain of 
R. etli pyruvate carboxylase. The BCCP-BC complex is shown in purple and gold, respectively, 
and the BCCP and BC domains of R. etli pyruvate carboxylase are shown in blue and green. A) 
Overlay of BC from E. coli with the BC domain from R. etli pyruvate carboxylase, PDB ID = 
2QF7. B) Overlay of BC from E. coli with the BC domain from R. etli pyruvate carboxylase, 
PDB ID = 3TW6. The dashed box indicates the loop in R. etli pyruvate carboxylase that would 
hinder E. coli BCCP binding. 
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covalently linked like the structures of similar biotin-dependent enzymes and, therefore, BCCP 
must be tethered to BC through non-covalent interactions. The differences observed here, 
however, do not preclude the possibility that the way BCCP interacts with the active site of BC is 
similar to pyruvate carboxylase (Lietzan et al., 2011). 
Implications for Antibacterial Development 
The dramatic increase in the number of pathogenic bacteria with extensive resistance to 
antibiotics has been well documented (Nathan, 2012; Spizek et al., 2010). Thus there is a 
pressing need for new targets and biotin carboxylase has been validated as a novel target for 
antibacterial development (Miller et al., 2009; Mochalkin et al., 2009). Given that the protein-
protein interface in E. coli BCCP-BC appears to be unique and presumably required for 
enzymatic activity, this greatly expands the number of potential target sites beyond just the 
traditional active sites. 
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CHAPTER 4 
CONCLUSIONS 
 
Summary 
 This dissertation addressed whether the subunits of E. coli acetyl-CoA carboxylase 
undergo the two half-reactions catalyzed by the enzyme separately or as a multifunctional 
complex. Specifically, does the BCCP interact with BC and CT separately to undergo the two 
half-reactions required to form malonyl-CoA, or do all three subunits come together to form a 
macromolecular complex? Since the late 1960’s, it has been assumed that a complex is formed 
but there has been minimal biochemical evidence to support this claim (Alberts et al., 1969; Fall 
and Vagelos, 1972; Nenortas and Beckett, 1996).  
Several techniques were utilized to show that acetyl-CoA carboxylase forms a complex. 
The array of enzyme kinetic studies showed that binding and catalysis at the BC active sites 
affects binding and catalysis at the CT active sites and vice versa. The BCCP-BC complex, 
which is likely the in vivo form of these proteins because free BCCP forms aggregates, was 
shown to not hydrolyze ATP unless CT and acetyl-CoA were present. To determine if the 
complex formed and if the presence or absence of ATP and/or acetyl-CoA had an effect on 
complex formation, co-immunoprecipitation assays were performed. The results confirmed that 
these components form a complex in vitro and the complex formation is not dependent on acetyl-
CoA or ATP analogs. Furthermore, in vivo overexpression of all four genes encoding the 
subunits of ACC form a functional ACC complex. These results suggested that all three 
components come together to form a complex that does not hydrolyze ATP until acetyl-CoA 
induces ACC to increase its catalytic reaction. 
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 The next step was to determine the three-dimensional structure of all or half of the acetyl-
CoA carboxylase complex. To this end, the three-dimensional structure of the BCCP-BC 
complex was determined by X-ray crystallography. This is the first complex of two ACC 
subunits observed to date. This structure showed three new interfaces formed by the two 
proteins. Four BCCP molecules each form two interfaces with different BC monomers, 
effectively clipping the complex together. The third interface is formed between the two BC 
homodimers that are clipped together. The unbiotinylated BCCP molecules were shown to be in 
a position where the BCCP-BC complex could interact with biotin protein ligase in order to 
attach the prosthetic group. Additionally, the large distance of the β-hairpin turn of BCCP to the 
active site provides structural evidence as to why BCCP-BC does not hydrolyze ATP in the 
absence of CT and acetyl-CoA. The BCCP and BC subunits superimpose well to previously 
determined biotin-dependent carboxylase structures but small differences like the loop extending 
out of the BC domain of R. etli pyruvate carboxylase would prevent the BCCP interaction with 
BC observed in the BCCP-BC complex. This complex is enzymatically active in the presence of 
CT and acetyl-CoA, which supports that the BCCP-BC structure is all or part of the functionally 
relevant molecule in E. coli. 
 These studies provide additional information on the recently proposed mechanism of CT 
regulation by Meades et al. (2010). Since both the BCCP-BC and ACC complexes form in vivo 
but do not hydrolyze ATP in the absence of acetyl-CoA, this presents a new regulatory archetype 
for acetyl-CoA carboxylase (Figure 4.1). During stationary phase when acetyl-CoA levels are 
low, the ACC complex does not hydrolyze ATP and binds the mRNA of its α-CT and β-CT 
subunits to attenuate translation. During log phase when acetyl-CoA levels are high, acetyl-CoA 
outcompetes mRNA for the CT active site to initiate fatty acid and CT synthesis (Figure 4.1). 
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This model can account for non-stoichiometric production of BCCP-BC complex or CT, 
whereby if BCCP-BC is overproduced then the N-terminal domain of BCCP is free to 
autoregulate transcription of the accBC gene and if CT is overproduced it binds its own mRNA 
preventing translation of CT. Therefore, acetyl-CoA levels directly control fatty acid synthesis in 
E. coli. 
 
Figure 4.1 Regulatory model of the acetyl-CoA carboxylase complex. 
 
Future Directions 
 The elucidation of the ACC complex and the structure of the BCCP-BC complex have 
generated several new avenues to study this macromolecular enzyme. The methods of purifying 
and assaying the ACC complex in Chapter 2 allows for testing of previously studied site-directed 
mutants of the individual subunits in the ACC complex. It will be interesting to see the extent of 
communication between the BC and CT active sites. For example, do the active site residues His 
209, Lys159, and Lys116, which are important for binding ATP in BC, have an effect on the 
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binding of acetyl-CoA to the complex (Sloane et al., 2001)? These active site mutations could 
provide insight into the mechanism of ACC activation by acetyl-CoA.  
 Inhibitors of BC and CT, such as 2-aminooxazole dibenzylamide and andrimid, 
respectively, were shown to have a synergistic effect on inhibition of the ACC complex. This 
substantiates the possibility that a dual-ligand inhibitor could inhibit ACC better than either 
molecule alone by tethering the molecule in proximity to the complex at two anchor points (the 
active sites) and locking the complex together in an inactive state. Furthermore, a dual-ligand 
inhibitor linking two BC inhibitors together with a short distance inbetween could inhibit BC 
activity as well as cause BCCP-BC complexes to aggregate before ACC is formed. 
 The BCCP-BC complex was unbiotinylated and it would be interesting to know if upon 
biotinylation, the BCCP molecules change positions on BC to a spot more favorable for catalysis 
and if the affinity for the CT subunit increases. Also, how does BCCP bind to the BC active site? 
Both questions first require the overexpression of BCCP and BC in the presence of biotin and 
separation of the biotinylated complex from the apo form. Subsequently, crystallization studies 
of the biotinylated complex cocrystallized with ATP, ADP, or carboxyphosphate analogs could 
provide the answer to both questions. 
 The subunit stoichiometry of the ACC complex remains elusive. The BCCP-BC complex 
shed some light on the stoichiometry and suggests a 1:1:1 arrangement of monomers of BC, 
BCCP, and each CT subunit. This is in agreement with the subunit organization in Pseudomonas 
citronellolis ACC (Choi-Rhee and Cronan, 2003; Fall, 1976) and the subunit and domain 
organization of the structures of propionyl-CoA carboxylase (Huang et al., 2010) and 
methylcrotonyl-CoA carboxylase (Huang et al., 2012). Furthermore, pyruvate carboxylase and 
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eukaryotic ACC express each subunit of E. coli ACC as a single domain on each polypeptide 
chain, which is also suggestive of a 1:1:1 ratio. However, the answer to this question will have to 
await the crystal structure of the ACC complex or further studies via methods like analytical 
ultracentrifugation or cryo-electron microscopy.  
The crystal structure of the BCCP-BC complex provides three unique interface targets to 
disrupt formation of the complex. The interface targets could prove useful in drug development 
considering the current difficulties in developing new and clinically relevant antibiotics targeting 
the BC and CT active sites (Freiberg et al., 2006; Katz et al., 2006; Mochalkin et al., 2009). 
Mutagenic analysis of interface residues will delineate which residues are important in complex 
formation. Then, creation of short peptide sequences or secondary structural elements that mimic 
the various interfaces could be used to try to disrupt the complex. This technique has been 
successfully used to disrupt the interaction between Bak (a protein that initiates apoptosis) and 
Bcl-2, a protein commonly expressed in cancer cells that binds Bak and prevents apoptosis (Chin 
and Schepartz, 2001). In an attempt to develop a novel anticancer agent Chin and Schepartz 
(2001) created a miniature protein using Bak interface residues grafted on avian pancreatic 
protein, which bound 100-fold tighter to Bcl-2 than Bak (Fletcher and Hamilton, 2006). Small 
molecule interface inhibitors of the BCCP-BC complex interfaces, similar to the Bak-Bcl-2 
studies, could yield novel lines of antibiotics to prevent initiation of fatty acid synthesis, which is 
greatly needed to combat the rising drug resistant microbes. 
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